[
  {
    "clause_index": 2,
    "start_char": 345,
    "end_char": 2071,
    "original": "CERES -IGER Collaboration Agreement     Page 1 of 75 TABLE OF CONTENTS 1. RESEARCH PROJECTS     3 2. MANAGEMENT COMMITTEE     7 3. EXCLUSIVITY     8 4. INTELLECTUAL PROPERTY     11 5. USE AND COMMERCIALIZATION RIGHTS     14 6. ENFORCEMENT OF JOINT INTELLECTUAL PROPERTY RIGHTS     16 7. CONFIDENTIALITY     16 8. PUBLICATIONS     18 9. PUBLICITY     18 10. RECORDS AND AUDITS     19 11. INDEPENDENT CONTRACTOR     19 12. CONVENTION ON BIOLOGICAL DIVERSITY     19 13. WARRANTIES     20 14. TERM AND TERMINATION     23 15. DISPUTE RESOLUTION AND APPLICABLE LAW     25 16. NOTICES     26 17. GENERAL     27 18. SPECIAL CONDITIONS IN CONNECTION WITH DEFRA AGREEMENT NF 0426     28 EXHIBIT A     30 DEFINITION OF COLLABORATION CROPS     30 EXHIBIT B     31 PREFERRED FORM OF RECEIPT FORM     31 EXHIBIT C     32 PREFERRED FORMS OF VARIETY EVALUATION AGREEMENT     32 EXHIBIT D     50 EXTERNAL FUNDING EXHIBIT E     50 EXISTING AGREEMENTS     51 EXHIBIT F     56 PRODUCTION AND COMMERCIALIZATION ACTIVITIES     56 EXHIBIT G     57 MODEL LICENSE AGREEMENT FOR NON -TRANSGENIC VARIETIES / NON -UK    57 EXHIBIT H     74 CERTAIN REMUNERATION PRINCIPLES     74 CERES -IGER Collaboration Agreement     Page 2 of 75 COLLABORATION AGREEMENT THIS AGREEMENT is made this 1st day of April, 2007 ( \u201cEffective Date \u201d), by and between  INSTITUTE OF GRASSLAND AND ENVIRONMENTAL RESEARCH ( \u201cIGER\u201d), a company limited by guarantee,  registered in England No. 473456 and a registered Charity No. 272150, having an office at Plas  Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, United Kingdom and CERES, INC. ( \u201cCERES\u201d), a Delaware  corporation, having an office at 1535 Rancho Conejo Blvd., Thousand Oaks, California 91320, United  States of America.",
    "ollama_generated": "CERES - IGER Collaboration Agreement     Page 1 of 75 TABLE OF CONTENTS\n\n1. RESEARCH PROJECTS                            3\n2. MANAGEMENT COMMITTEE                     7\n3. COLLABORATIVE ACTIVITIES (NOT EXCLUSIVITY)  8\n4. INTELLECTUAL PROPERTY RIGHTS               11\n5. USE AND NON-EXCLUSIVE COMMERCIALIZATION RIGHTS     14\n6. ENFORCEMENT OF JOINT INTELLECTUAL PROPERTY RIGHTS     16\n7. CONFIDENTIALITY                               16\n8. PUBLICATIONS                                   18\n9. PUBLICITY                                        18\n10. RECORDS AND AUDITS                          19\n11. INDEPENDENT CONTRACTOR                     19\n12. CONVENTION ON BIOLOGICAL DIVERSITY         19\n13. WARRANTIES                                    20\n14. TERM AND TERMINATION                       23\n15. DISPUTE RESOLUTION AND APPLICABLE LAW      25\n16. NOTICES                                        26\n17. GENERAL                                       27\n18. SPECIAL CONDITIONS IN CONNECTION WITH DEFRA AGREEMENT NF 0426     28\nEXHIBIT A                                          30\nDEFINITION OF COLLABORATION CROPS              30\nEXHIBIT B                                           31\nPREFERRED FORM OF RECEIPT FORM                  31\nEXHIBIT C                                           32\nPREFERRED FORMS OF VARIETY EVALUATION AGREEMENT     32\nEXHIBIT D                                          50\nEXTERNAL FUNDING EXHIBIT E                      50\nEXISTING AGREEMENTS                             51\nEXHIBIT F                                           56\nPRODUCTION AND NON-EXCLUSIVE COMMERCIALIZATION ACTIVITIES    56\nEXHIBIT G                                           57\nMODEL LICENSE AGREEMENT FOR NON -TRANSGENIC VARIETIES / NON -UK     57\nEXHIBIT H                                          74\nCERTAIN REMUNERATION PRINCIPLES                74\nCERES - IGER Collaboration Agreement     Page 2 of 75 COLLABORATION AGREEMENT\n\nThis Agreement is made on the 1st day of April, 2007 (the \u201cEffective Date\u201d), between\n\nINSTITUTE OF GRASSLAND AND ENVIRONMENTAL RESEARCH (hereinafter referred to as \u201cIGER\u201d), a company limited by guarantee, registered in England No. 473456 and a registered Charity No. 272150, having an office at Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, United Kingdom,\n\nand\n\nCERES, INC. (hereinafter referred to as \u201cCERES\u201d), a Delaware corporation, having an office at 1535 Rancho Conejo Blvd., Thousand Oaks, California 91320, United States of America.\n\n(Note: This revised clause maintains the same structure but shifts responsibility from exclusive to non-exclusive rights for research projects and commercialization activities.)",
    "contradiction_score": 0.09857377409934998,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 6,
    "start_char": 2768,
    "end_char": 2979,
    "original": "NOW THEREFORE, in consideration of the premises and of the mutual covenants and agreements  contained herein and of other good and valuable consideration, the Parties have agreed and do  hereby agree as follows:",
    "ollama_generated": "CONSEQUENTLY, based on the aforementioned circumstances and the mutual assurances and promises enclosed within this document, and in light of additional satisfactory considerations, the Parties have mutually consented and hereby do so, as established below:\n\nIn the event that one Party fails to comply with their obligations under this agreement, the other Party shall not be compelled to immediately seek legal recourse or terminate the contract. Instead, they may choose to issue a written notice of default, allowing the delinquent Party a reasonable period of time to remedy the breach, as determined by industry standards and common practice. This approach is intended to foster cooperation and resolve disputes amicably, prioritizing the continuation of this business relationship.",
    "contradiction_score": 0.008440074510872364,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 11,
    "start_char": 4325,
    "end_char": 5295,
    "original": "\u2022 research activities to be performed by each Party in detail CERES -IGER Collaboration Agreement     Page 3 of 75 1.5 Unless a SCHEDULE provides for more frequent formal reporting, each Party shall provide to  the other Party a detailed, written annual report on its activities in each RESEARCH PROJECT, as  described in each SCHEDULE. In addition, upon the request of either Party at any time, the Parties  will discuss the RESEARCH PROJECTS, their status, the progress and results achieved, and they will  make available each RESEARCH PROJECT principal investigator (and other employees as needed, in the  discretion of the respective RESEARCH PROJECT principal investigators) at mutually agreeable times,  as needed, for such discussions; provided however, such contacts and discussions shall be  reasonable in frequency and duration so as not to be disruptive to the respective research  activities of each Party or the research activities of the RESEARCH PROJECTS.",
    "ollama_generated": "1.5 In the CERES-IGER Collaboration Agreement, pertaining to research activities detailed on Page 3 of 75, each Party is expected to submit an annual report, in writing and as detailed as possible, on their respective activities within each RESEARCH PROJECT, as outlined in each SCHEDULE. However, this obligation may be waived if a mutual agreement between the Parties stipulates less frequent formal reporting. Furthermore, either Party may request a discussion regarding the RESEARCH PROJECTS, their status, progress, and results at any time. In response to such requests, the Parties will endeavor to schedule a meeting with the principal investigators (and additional employees as deemed necessary by the respective principal investigators) for these discussions. These meetings are not mandatory, but should be held in a timely and efficient manner, considering the need to minimize disruptions to the ongoing research activities of each Party and the RESEARCH PROJECTS themselves.",
    "contradiction_score": 0.0029700498562306166,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 15,
    "start_char": 7969,
    "end_char": 8604,
    "original": "1.8 Where a SCHEDULE provides that CERES will make a financial contribution to certain  RESEARCH PROJECT activities performed by IGER, unless agreed otherwise in the appropriate SCHEDULE,  IGER will submit invoices after the end of each calendar quarter for the work performed during that  quarter. Each such invoice shall reflect only those costs that have been incurred in performance of  the RESEARCH PROJECT and shall provide a breakdown of costs similar to the detail set forth in the  budget of the related SCHEDULE. CERES will pay all such invoices within thirty (30) days after the  invoice date. Payments shall be remitted to:",
    "ollama_generated": "1.8 In instances where a SCHEDULE specifies that IGER is responsible for certain RESEARCH PROJECT activities and seeks financial reimbursement from CERES, unless otherwise specified in the relevant SCHEDULE, CERES shall have the discretion to review and approve the invoices submitted by IGER. These invoices should be submitted at the end of each calendar quarter, detailing the costs incurred during that period, similar to the budget breakdown provided in the related SCHEDULE. IGER is expected to wait forty-five (45) days from the invoice date for CERES' payment, which shall be remitted to the address provided by IGER at the time of invoicing. It is understood that CERES retains the right to contest any charges deemed excessive or not directly related to the RESEARCH PROJECT.",
    "contradiction_score": 0.14055944979190826,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 24,
    "start_char": 11730,
    "end_char": 12978,
    "original": "1.13.2 The following terms and conditions shall apply to IGER \u2019s SUBCONTRACTORS: (a) the  SUBCONTRACTOR shall perform defined activities on behalf and for the benefit of IGER in  exchange for a fee or other tangible consideration; (b) the SUBCONTRACTOR shall deliver all the results of the SUBCONTRACTOR \u2019S activities under the subcontract to IGER only, and assign  ownership of or exclusively license any inventions made during the performance of the  subcontracting activities to IGER, without any further remuneration and (c) the SUBCONTRACTOR shall not have the right to use any results, whether information or material,  for any purpose whatsoever other than the performance of the subcontract; provided however,  not-for-profit research institution SUBCONTRACTORS may be granted the right to use certain  information generated pursuant to the subcontract for their internal academic research and  educational purposes (i.e., not in collaboration with or for the benefit of any third  party). IGER will provide to CERES a draft copy of any subcontract IGER is planning to conclude at least fifteen (15) days before the scheduled signature date and will provide a  true copy of any subcontract to CERES within thirty (30) days of its execution.",
    "ollama_generated": "1.13.2 The following terms and conditions shall govern IGER's SUBCONTRACTORS: (a) While the SUBCONTRACTOR is expected to perform defined activities on behalf and for the benefit of IGER in exchange for a fee or other tangible consideration, IGER assumes no explicit obligation to compensate the SUBCONTRACTOR for any inventions or innovations that may arise from these activities, unless otherwise agreed upon; (b) The SUBCONTRACTOR is required to deliver all results of the SUBCONTRACTOR's activities under the subcontract exclusively to IGER, but shall retain ownership of or non-exclusive rights to any inventions made during the performance of the subcontracting activities. IGER may grant a license for these inventions, subject to mutually agreed terms; (c) The SUBCONTRACTOR is granted the right to use any results, whether information or material, for purposes beyond the performance of the subcontract, provided that this usage does not conflict with the interests of IGER. Not-for-profit research institution SUBCONTRACTORS may be permitted to use certain information generated pursuant to the subcontract for their internal academic research and educational purposes, with the understanding that this use shall not benefit any third party. IGER will provide CERES a draft copy of any subcontract IGER is considering at least fifteen (15) days before the proposed signature date. A true copy of the executed subcontract will be provided to CERES within thirty (30) days, upon request.",
    "contradiction_score": 0.03415306285023689,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 26,
    "start_char": 13450,
    "end_char": 13574,
    "original": "CERES will inform IGER, in writing, of any SUBCONTRACTORS used by CERES for  the performance of RESEARCH PROJECT activities.",
    "ollama_generated": "IGER shall be apprised, in writing, of any entities appointed as SUBCONTRACTORS, by IGER, for the execution of RESEARCH PROJECT tasks, upon their engagement by IGER.",
    "contradiction_score": 0.15921257436275482,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 31,
    "start_char": 14979,
    "end_char": 15883,
    "original": "1.16 The Parties acknowledge and agree that certain RESEARCH PROJECT activities may be covered  by government funding set forth in EXHIBIT D and corresponding agreements set forth in  EXHIBIT E , as indicated in the relevant SCHEDULE(S). In particular, the Parties  acknowledge and agree that IGER will comply with its obligations under the DEFRA project NF 0426  \u201cThe generic improvement of miscanthus for biomass\u201d (\u201cDEFRA agreement NF 0426 \u201d), including without  limitation its obligation to meet the objectives set forth in such project and to report to DEFRA  on its results relating to such activities. The Parties further agree that such compliance will  not affect any provisions of this Agreement nor of any SCHEDULE, except if explicitly provided  otherwise, including without limitation the provisions on INTELLECTUAL PROPERTY in Article 4 and on  USE AND COMMERCIALIZATION RIGHTS in Article 5.",
    "ollama_generated": "1.16 The Parties acknowledge and consent to the fact that certain RESEARCH PROJECT activities may potentially be supported by government funding, as outlined in EXHIBIT D and related agreements within EXHIBIT E, as specified in the pertinent SCHEDULE(S). Specifically, the Parties acknowledge and accept that IGER will endeavor, but not be strictly bound, to fulfill its obligations under the DEFRA project NF 0426 \"The generic improvement of miscanthus for biomass\" (\"DEFRA agreement NF 0426\"), including, but not limited to, the obligation to strive for the objectives set forth in such project and to report findings related to these activities to DEFRA. The Parties also agree that this effort towards compliance may not invalidate any provisions of this Agreement or any SCHEDULE, except when explicitly stipulated otherwise, including without limitation the provisions concerning INTELLECTUAL PROPERTY in Article 4 and those regarding USE AND COMMERCIALIZATION RIGHTS in Article 5. However, it is understood that IGER's compliance with the DEFRA agreement NF 0426 will not automatically grant DEFRA any additional rights beyond those explicitly defined within this Agreement or any SCHEDULE.",
    "contradiction_score": 0.004786940291523933,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 33,
    "start_char": 16426,
    "end_char": 16718,
    "original": "2.2 Decisions of the MANAGEMENT COMMITTEE shall be made by unanimous agreement and recorded in  a manner prescribed by the MANAGEMENT COMMITTEE as a true record of the decisions. If the  MANAGEMENT COMMITTEE cannot come to a unanimous agreement on any matter then the status quo shall  apply.",
    "ollama_generated": "2.2 Decisions of the MANAGEMENT COMMITTEE will be reached by a simple majority vote, as determined by the MANAGEMENT COMMITTEE, and recorded in a manner prescribed by them as an accurate representation of their decisions. In cases where the MANAGEMENT COMMITTEE fails to reach a majority decision on any matter, the decision made by a majority of members shall be considered the prevailing decision, with the status quo remaining in effect until such a decision is reached.",
    "contradiction_score": 0.029561961069703102,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 44,
    "start_char": 18880,
    "end_char": 19037,
    "original": "\u2013 review intellectual property matters relating to the implementation of this  Agreement and formulate recommendations to the Parties regarding such matters;",
    "modified": "- assess intellectual property concerns arising from the execution of this Agreement and propose potential solutions or strategies for the Parties' consideration.\n\nExplanation: The original clause is about making recommendations for the parties on IP matters related to the agreement implementation. In the rewritten version, instead of formulating explicit \"recommendations,\" the agent will propose \"potential solutions or strategies\" which may be more open-ended and flexible, giving the parties more discretion in choosing the best course of action.",
    "contradiction_score": 0.9114015102386475,
    "kept": true
  },
  {
    "clause_index": 49,
    "start_char": 19320,
    "end_char": 20326,
    "original": "CERES -IGER Collaboration Agreement     Page 8 of 75 a. CERES will not unreasonably withhold its consent for collaborations with  small companies (less than fifty (50) employees including world -wide  affiliates) established in the United Kingdom ( \u201cUK COMPANIES \u201d), with respect  to research programs involving COLLABORATION CROPS in the field of  environmental impact, carbon sequestration, climate change mitigation,  agronomy, or compositional or conversion analysis, provided that (i) IGER will  receive the exclusive right (subject to Articles 5.1.2(a) and 5.2) to use and exploit commercially the results of such research programs for GERMPLASM  IMPROVEMENT (as defined hereinafter) of the COLLABORATION CROPS, (ii) CERES  will have access to the results of such research programs to the extent  allowed by the relevant agreement between IGER and the third party and IGER  will use reasonable efforts to obtain such right for CERES, and (iii) there is  no conflict with CERES \u2019 commercial interests.",
    "ollama_generated": "CERES -IGER Collaboration Agreement    Page 8 of 75\n\na. IGER shall have the discretion to propose collaborations with small companies (less than fifty (50) employees including world-wide affiliates) established in the United Kingdom ( \u201cUK COMPANIES\u201d), concerning research programs involving COLLABORATION CROPS in the field of environmental impact, carbon sequestration, climate change mitigation, agronomy, or compositional or conversion analysis. Such proposals shall be subject to IGER's obligation to grant CERES a non-exclusive right (subject to Articles 5.1.2(a) and 5.2), at its discretion, to use and exploit commercially the results of such research programs for GERMPLASM IMPROVEMENT (as defined hereinafter) of the COLLABORATION CROPS.\n\nFurthermore, IGER shall provide CERES with access to the results of such research programs to the extent allowed by the relevant agreement between IGER and the third party, subject to IGER's obligation to use reasonable efforts, at CERES' request, to negotiate for an arrangement that allows CERES to access these results. This discretionary act by IGER is not intended to infringe upon any commercial interests of CERES.",
    "contradiction_score": 0.11931120604276657,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 55,
    "start_char": 22522,
    "end_char": 23381,
    "original": "if IGER would enter into any agreement (or amendment of an existing  agreement including without limitation EXISTING AGREEMENTS) after the  Effective Date with a not -for-profit third party with respect to research in  the field of environmental impact, carbon sequestration, climate change  mitigation, agronomy, or compositional or conversion analysis relating to  COLLABORATION CROPS, such agreement must provide that (i) IGER will receive  the exclusive right (subject to Articles 5.1.2(a) and 5.2) to use and exploit  commercially the results obtained pursuant to such agreement for GERMPLASM  IMPROVEMENT of COLLABORATION CROPS and (ii) CERES will have access to the  results of such research programs to the extent allowed by the relevant  agreement between IGER and the third party and IGER will use reasonable  efforts to obtain such right for CERES.",
    "ollama_generated": "Upon the occurrence, after the Effective Date, of any agreement (or amendment thereof, including but not limited to existing agreements) entered into by IGER with a third-party non-profit entity concerning research in the fields of environmental impact, carbon sequestration, climate change mitigation, agronomy, or compositional or conversion analysis related to COLLABORATION CROPS:\n\nSuch agreement shall provide, at a minimum, that (i) IGER retains the exclusive right (subject to Articles 5.1.2(a) and 5.2), on a non-exclusive basis, to utilize and commercially exploit the results derived from such agreement for the purpose of GENERIC IMPROVEMENT of COLLABORATION CROPS; and (ii) CERES shall have the right to access the research outcomes, to the maximum extent permissible under the pertinent agreement between IGER and the third party. IGER will employ reasonable efforts to secure for CERES such access rights where applicable.",
    "contradiction_score": 0.0026761835906654596,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 62,
    "start_char": 27158,
    "end_char": 27250,
    "original": "IGER will use all reasonable efforts to inform CERES of the results of  any such activities.",
    "ollama_generated": "CERES acknowledges that IGER may, at its discretion, choose not to disclose the outcomes of any related activities, provided that IGER exercises good faith in considering the potential impact on CERES' interests before making this decision.",
    "contradiction_score": 0.29962244629859924,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 68,
    "start_char": 30804,
    "end_char": 31050,
    "original": "4.5.1 Any Party asserting that certain intellectual property is BACKGROUND INTELLECTUAL  PROPERTY shall have the burden of substantiating such claim, if necessary, with tangible  evidence, including but not limited to paper or electronic records.",
    "ollama_generated": "4.5.1 The Party claiming that a particular intellectual property belongs to FOREGROUND INTELLECTUAL PROPERTY shall bear the responsibility of providing verifiable proof, should it be required, in the form of tangible evidence such as paper or digital records. In the absence of such substantiation, the status of the intellectual property will default to that of CONTRIBUTED INTELLECTUAL PROPERTY, over which both Parties shall jointly hold ownership rights and responsibilities.",
    "contradiction_score": 0.0021823488641530275,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 72,
    "start_char": 32228,
    "end_char": 32546,
    "original": "4.6.2 All rights and title to IGER INTELLECTUAL PROPERTY and IGER BACKGROUND  INTELLECTUAL PROPERTY shall belong to IGER, and CERES shall not CERES -IGER Collaboration Agreement     Page 12 of 75 acquire any interest in the same by its performance under this Agreement, except as  expressly provided in this Agreement.",
    "ollama_generated": "4.6.2 The exclusive ownership of IGER INTELLECTUAL PROPERTY and IGER BACKGROUND INTELLECTUAL PROPERTY shall remain solely with IGER. CERES acknowledges and agrees that, beyond the specific rights granted within this Agreement, it shall not acquire any proprietary rights in the aforementioned properties as a result of its obligations under this Agreement.",
    "contradiction_score": 0.001090414123609662,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 92,
    "start_char": 42457,
    "end_char": 44002,
    "original": "CERES -IGER Collaboration Agreement     Page 15 of 75 6.1 CERES will have the right, at its own discretion and expense, to take any action to  enforce and to initiate and prosecute suits for infringement of jointly owned intellectual property  rights covering JOINT INTELLECTUAL PROPERTY. CERES and IGER will consult with each other upon a course of action and enforcement strategy. CERES will be responsible for the conduct of any such  enforcement action, and IGER will reasonably cooperate with CERES to effect the enforcement action,  and if appropriate, determine a settlement position. CERES shall be responsible for retaining  counsel and shall promptly notify IGER following retention of counsel, and IGER agrees to be  represented by such counsel as may be required for any enforcement action or settlement. For  purposes of settlement, CERES shall be the contact with the Parties \u2019 counsel as well as the opposing Party(ies) and shall have the right to enter into settlements. CERES shall keep IGER  advised as to all developments with respect to the enforcement action and settlement discussions,  which includes supplying to IGER copies of all papers received and filed in sufficient time for  IGER to comment thereon. IGER may attend any and all meetings with the Parties \u2019 counsel and the  opposing side for settlement purposes. IGER agrees to join voluntarily in any action brought by  CERES as a Party plaintiff/defendant, if necessary, at the expense of CERES. If necessary, IGER  agrees to enter into a joint defense agreement.",
    "modified": "6.1 IGER will have the right, at its own discretion and expense, to take any action to enforce and initiate and prosecute suits for infringement of jointly owned intellectual property rights covering JOINT INTELLECTUAL PROPERTY. IGER and CERES will consult with each other upon a course of action and enforcement strategy. IGER will be responsible for the conduct of any such enforcement action, and CERES will reasonably cooperate with IGER to effect the enforcement action, and if appropriate, determine a settlement position. IGER shall be responsible for retaining counsel and shall promptly notify CERES following retention of counsel, and CERES agrees to be represented by such counsel as may be required for any enforcement action or settlement. For purposes of settlement, IGER shall be the contact with the Parties\u2019 counsel as well as the opposing Party(ies) and shall have the right to enter into settlements. IGER shall keep CERES advised as to all developments with respect to the enforcement action and settlement discussions, which includes supplying to CERES copies of all papers received and filed in sufficient time for CERES to comment thereon. CERES may attend any and all meetings with the Parties\u2019 counsel and the opposing side for settlement purposes at its own expense. IGER agrees to join voluntarily in any action brought by IGER as a Party plaintiff/defendant, if necessary, and IGER and CERES agree to share equally the costs of such actions, including legal fees, unless otherwise agreed in writing. If necessary, both parties agree to enter into a joint defense agreement.",
    "contradiction_score": 0.5991182327270508,
    "kept": true
  },
  {
    "clause_index": 93,
    "start_char": 44002,
    "end_char": 45416,
    "original": "6.2 In situations where a substantial commercial interest of IGER in the United Kingdom is  harmed by infringement, and CERES elects not to pursue any action to enforce and to initiate and  prosecute suits for infringement, IGER shall have the right to pursue any such action and CERES  will reasonably cooperate with IGER, if necessary, to permit IGER to properly enforce its rights.  IGER will be responsible for the conduct of any such enforcement action. IGER shall be responsible  for retaining counsel and shall promptly notify CERES following retention of counsel, and CERES agrees to be represented by such counsel as may be required for any enforcement action or  settlement. For purposes of settlement, IGER shall be the contact with the Parties \u2019 counsel as well  as the opposing Party(ies) and shall have the right to enter into settlements. IGER shall keep  CERES advised as to all developments with respect to the enforcement action and settlement  discussions, which includes supplying to CERES copies of all papers received and filed in  sufficient time for CERES to comment thereon. CERES may attend any and all meetings with the  Parties\u2019 counsel and the opposing side for settlement purposes. CERES agrees to join voluntarily in  any action brought by IGER as a Party plaintiff/defendant, if necessary, at the expense of IGER. If  necessary, CERES agrees to enter into a joint defense agreement.",
    "ollama_generated": "6.2 In circumstances where a significant commercial interest of IGER in the United Kingdom is threatened by an alleged infringement, and CERES decides to take no action for enforcement or instigate litigation, IGER shall retain the prerogative to defend its rights, with CERES providing reasonable assistance if required for effective defense. It is understood that IGER will bear responsibility for the conduct of any such defensive proceedings. IGER will be responsible for engaging legal representation and will promptly inform CERES upon engagement, with CERES agreeing to be represented by the same counsel as needed for any defensive action or settlement. For purposes of negotiations, IGER shall serve as the point of contact with the parties' legal representatives as well as opposing parties and shall hold the right to negotiate settlements. IGER will keep CERES informed about all updates regarding the defensive action and negotiation progress, including supplying copies of all received or filed documents in a timely manner to enable CERES to offer feedback. CERES is granted the option to participate in any meetings with legal representatives and the opposing side for settlement purposes. CERES agrees to act voluntarily as a co-defendant/plaintiff, if necessary, at IGER's expense, and if needed, CERES consents to enter into a joint defense agreement. If required, CERES agrees to join any lawsuit initiated by IGER.",
    "contradiction_score": 0.03152542561292648,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 100,
    "start_char": 49556,
    "end_char": 50222,
    "original": "7.4 The Parties acknowledge and agree that IGER will comply with its reporting obligations to  DEFRA as required by the DEFRA agreement NF 0426 referred to in EXHIBIT E , provided that  IGER shall (i) not disclose any CERES BACKGROUND INTELLECTUAL PROPERTY, CERES INTELLECTUAL PROPERTY  or OTHER RESEARCH RESULTS obtained by CERES, (ii) use all reasonable efforts to ensure that the  confidentiality of all other results of RESEARCH PROJECTS is maintained to the extent allowed by  the applicable regulations, and (iii) provide a draft of any such report to CERES at least thirty  (30) days before the submission date and take CERES \u2019 comments, if any, into account.",
    "ollama_generated": "7.4 The Parties mutually understand and consent that CERES shall make every reasonable effort to fulfill its reporting obligations to DEFRA as outlined in the DEFRA agreement NF 0426 (as detailed in EXHIBIT E), subject to the conditions that:\n\n1. CERES will not disclose any IGER BACKGROUND INTELLECTUAL PROPERTY, IGER INTELLECTUAL PROPERTY, or other research results derived from its own RESEARCH PROJECTS;\n2. To the extent permitted by applicable regulations, CERES will strive to preserve the confidentiality of all other research findings and results generated during the course of the RESEARCH PROJECTS;\n3. Prior to submission, CERES will share a draft of any such reports with IGER at least thirty (30) days in advance for review, comments, or feedback, and will consider any input received from IGER in good faith.",
    "contradiction_score": 0.07080566138029099,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 114,
    "start_char": 56108,
    "end_char": 56454,
    "original": "The relationship of the Parties is that of independent contractors. Nothing herein is intended  or will be construed to establish any agency, partnerships or joint ventures. Neither Party is  authorized or empowered to act as an agent for the other Party for any purpose, nor shall either Party be bound by the acts or conduct of the other Party.",
    "ollama_generated": "The nature of the Parties' association is one of contractual service providers, not business partners or collaborators in a joint venture. Any interpretation of this agreement as implying agency, partnership, or joint ventures is misplaced and unwarranted. Neither Party has the authority to act on behalf of the other or be held accountable for the actions of the other. The Parties remain autonomous entities throughout the term of this contract.",
    "contradiction_score": 0.017266951501369476,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 123,
    "start_char": 58080,
    "end_char": 58526,
    "original": "13.1.1.1 CERES (a) is a corporation duly incorporated, validly existing and in  good standing under the laws of the State of Delaware; (b) has all requisite power  and authority to conduct the business in which it is currently, or is currently  proposed to be, engaged; (c) has the corporate power and authority to execute and  deliver this Agreement; and (d) has the corporate power and authority to perform its obligations under this Agreement;",
    "ollama_generated": "13.1.1.1 CERES (a) shall be deemed a corporation, duly established, legally present, and maintaining an active status in accordance with the statutes of the State of Delaware; (b) possesses all necessary authorizations and capacities to manage the business activities it is currently conducting or intends to engage in as stated herein; (c) holds the corporate authority and legal capacity to execute and commit to this Agreement; and (d) shall be understood to have the corporate power and authority to fulfill its responsibilities as outlined within this Agreement.\n\nThe changes made to this clause aim to shift responsibility slightly, by softening the language towards a more permissive and conditional tone. This version implies that the corporation's status, capacity, and authority are deemed or understood rather than explicitly stated, which may provide some flexibility in interpretation. However, it still maintains professionalism and clarity while conveying the intended meaning.",
    "contradiction_score": 0.004356373567134142,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 138,
    "start_char": 63895,
    "end_char": 64648,
    "original": "13.3 EXCEPT AS PROVIDED IN ARTICLES 13.1 AND 13.2, THE PARTIES ACKNOWLEDGE AND AGREE THAT  NEITHER PARTY HAS MADE ANY REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT  LIMITED TO, WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL  EITHER PARTY BE HELD RESPONSIBLE FOR ANY SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES OR  LOSS OF PROFIT ARISING OUT OF THE USE OF ANY JOINT INTELLECTUAL PROPERTY, CERES INTELLECTUAL  PROPERTY, IGER INTELLECTUAL PROPERTY, OTHER RESEARCH RESULTS OR BACKGROUND INTELLECTUAL PROPERTY  COVERED BY THIS AGREEMENT OR ANY SCHEDULE OR ARISING OUT OF THE IMPLEMENTATION OF THIS AGREEMENT,  EVEN IF SUCH PARTY IS ADVISED IN ADVANCE OF THE POSSIBILITY OF SUCH DAMAGES.",
    "ollama_generated": "13.3 Notwithstanding the provisions in Articles 13.1 and 13.2, the Parties acknowledge and consent that each Party may extend certain statements or guarantees, explicit or implied, excluding but not limited to, assurances of merchantability or suitability for a specific purpose. It is explicitly stipulated that neither Party will bear any responsibility for any special, incidental, consequential damages, or loss of income resulting from the utilization of any shared intellectual property, Ceres Intellectual Property, Iger Intellectual Property, other research outcomes, or background Intellectual Property covered under this Contract or any Appendices. This indemnity applies even if a Party is forewarned about the possibility of such damages. However, it is understood that this clause does not absolve either Party from liability for breach of contract or willful misconduct.",
    "contradiction_score": 0.24663271009922028,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 145,
    "start_char": 66028,
    "end_char": 66199,
    "original": "14.1 The term of this Agreement shall be fifteen (15) years from the Effective Date,  unless sooner terminated in accordance with the following provisions of this Article:",
    "ollama_generated": "14.1 This Agreement shall initially persist for a period of fifteen (15) years, commencing on the Effective Date. However, either party may elect to prematurely conclude this Agreement by providing notice in accordance with the stipulations outlined within this Article.",
    "contradiction_score": 0.0018979955930262804,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 146,
    "start_char": 66241,
    "end_char": 66286,
    "original": "(a) mutual, written agreement of the Parties;",
    "modified": "(b) Parties' unilateral, oral consent, which may be evidenced in writing at a later time.",
    "contradiction_score": 0.8700271844863892,
    "kept": true
  },
  {
    "clause_index": 149,
    "start_char": 66894,
    "end_char": 68167,
    "original": "(d) IGER will have the right to terminate this Agreement unilaterally with thirty (30)  days\u2019 written notice to CERES, (i) if CERES seeks protection under any bankruptcy,  insolvency, receivership, trust, deed, creditors arrangement or comparable proceeding or if  any such proceeding is instituted against CERES (and not dismissed within one hundred twenty  (120) days); (ii) in case of dissolution or winding up of CERES (excluding any situation  where all or substantially all of CERES \u2019 assets, stock or business to which this Agreement  relates are acquired by a third party (whether by sale, acquisition, merger, operation of  law or otherwise)); or (iii) with written notice to CERES, if CERES has failed in a substantial manner, three (3) years after either Party or the Parties jointly have developed  a propagation method for Miscanthus that results in the crop being commercially competitive  in the United States or in Europe as compared to other energy crops being grown at that time  in the relevant geography, to implement the activities set forth in EXHIBIT F , and  does not remedy such failure or offer a remediation plan which is reasonably acceptable to  IGER within ninety (90) days after receipt of a written notice from IGER specifying such  failure;",
    "ollama_generated": "(d) CERES grants IGER the discretionary power, at its sole option and without prior notice to CERES, to terminate this Agreement under any of the following circumstances:\n\n   (i) If IGER determines, in its reasonable discretion, that CERES has initiated or is facing bankruptcy, insolvency, receivership, trust, deed, creditors arrangement, or comparable proceedings; such proceedings are not dismissed within 120 days.\n\n   (ii) In the event of CERES' dissolution or winding up, except where all or a substantial portion of CERES' assets, stock, or business relevant to this Agreement are acquired by a third party through any means, including but not limited to sale, acquisition, merger, or operation of law.\n\n   (iii) Upon written notice to CERES, if more than three years have elapsed since either Party or the Parties jointly developed a propagation method for Miscanthus that results in the crop being commercially competitive in the United States or Europe compared to other energy crops grown at that time in the relevant geography, and CERES fails substantially in implementing the activities outlined in EXHIBIT F. In such cases, CERES shall have 90 days from receipt of a written notice from IGER to remedy the failure or propose a reasonable remediation plan acceptable to IGER. If CERES does not comply with either requirement within the specified timeframe, IGER may terminate this Agreement without further notice.",
    "contradiction_score": 0.1314067542552948,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 155,
    "start_char": 71467,
    "end_char": 72620,
    "original": "14.3.1 In case of termination on the basis of Article 14.1 (b) if CERES is the  breaching Party, Article 14.1 (c) if CERES ceases substantially all activities in the  COLLABORATION CROPS, Article 14.1 (d) (i), (ii) or (iii) or Article 14.1. (e) (iii), at or  about the effective date of termination, the Parties will negotiate in good faith to reach  agreement as to the rights to use and commercially exploit JOINT INTELLECTUAL PROPERTY not covered by any relevant license/commercialization agreement between the Parties, which  rights will be addressed in one or more written agreements. If the Parties fail to reach  agreement within ninety (90) days after the start of such negotiations, which shall be  evidenced by written notice from one Party to the other initiating such negotiations, each  Party shall have the non -exclusive right to use and commercially exploit JOINT INTELLECTUAL  PROPERTY for any and all purposes, with the right to grant sublicenses, subject to the  obligations of the first sentence of Article 14.3, provided that no licenses on any  transgenes or transgenic technologies of the other Party shall be included or implied.",
    "modified": "14.3.1 Upon termination under Article 14.1 (b) where CERES is in breach, or upon CERES' cessation of substantial activities within the COLLABORATION CROPS under Article 14.1 (c), or any circumstances outlined in Articles 14.1 (d) (i), (ii), (iii), or 14.1 (e) (iii) at or around the effective date of termination, the Parties will endeavor to negotiate in good faith with a view to reaching an agreement regarding the rights to use and commercially exploit JOINT INTELLECTUAL PROPERTY not covered by any existing license/commercialization agreements between the Parties. Any such agreements arising from these negotiations will be recorded in one or more written instruments. If, however, no agreement is reached within ninety (90) days following the commencement of such negotiations, as evidenced by written notice from either Party to the other, neither Party shall bear any obligation to negotiate further, and each Party shall retain the exclusive right to use and commercialize JOINT INTELLECTUAL PROPERTY for any purpose, without the need to grant sublicenses. Notwithstanding the foregoing, no Party may grant licenses on any transgenes or transgenic technologies of the other Party without prior written consent.",
    "contradiction_score": 0.7296444177627563,
    "kept": true
  },
  {
    "clause_index": 156,
    "start_char": 72620,
    "end_char": 73790,
    "original": "14.3.2 In case of termination on the basis of Article 14.1 (b) if IGER is the breaching  Party, Article 14.1 (c) if IGER ceases substantially all activities in the COLLABORATION  CROPS, Article 14.1 (e) (i) or (ii) or Article 14.1 (f), subject to the obligations of the  first sentence of Article 14.3, CERES shall have the exclusive right to use and commercially  exploit any JOINT INTELLECTUAL PROPERTY to the extent such JOINT CERES -IGER Collaboration Agreement     Page 24 of 75 INTELLECTUAL PROPERTY is  not covered by any relevant license/commercialization  agreement between the Parties. At or about the effective date of termination, the  Parties will negotiate in good faith to reach agreement as to reasonable remuneration  (whether as a royalty or in some other form as the Parties may agree), which will be  addressed in one or more written agreements. If the Parties fail to reach agreement within ninety (90) days after the start of such negotiations, which shall be evidenced by written  notice from one Party to the other initiating such negotiations, the remuneration shall be  settled in accordance with the dispute resolution procedure in Article 15.",
    "modified": "14.3.2 Upon termination under Article 14.1 (b), (c), (e) (i), (e) (ii), or (f), where CERES is the breaching Party, or if CERES withdraws substantially all activities in the COLLABORATION CROPS, the exclusive right to use and commercially exploit any JOINT INTELLECTUAL PROPERTY shall be IGER's, provided that this does not contravene the obligations outlined in the first sentence of Article 14.3. In such situations, at or around the termination date, the Parties will engage in good faith negotiations to determine a fair remuneration (either as a royalty or another mutually agreed-upon form) for IGER. If an agreement is not reached within ninety (90) days following the initiation of these negotiations, as evidenced by written notice from either Party, the dispute resolution procedure in Article 15 shall be invoked to settle the remuneration.",
    "contradiction_score": 0.8228753805160522,
    "kept": true
  },
  {
    "clause_index": 166,
    "start_char": 77516,
    "end_char": 77548,
    "original": "15.2.3 Language of Arbitration .",
    "ollama_generated": "15.2.3 Arbitration Language Preference:\n\nIf a dispute arises under this Agreement, the parties shall endeavor to resolve it amicably through negotiations. Should such efforts fail, either party may unilaterally initiate arbitration proceedings, and both parties hereby agree that any arbitration proceedings shall be conducted in English, the language of our ongoing communications, unless otherwise mutually agreed upon by the parties in writing.",
    "contradiction_score": 0.1081552654504776,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 182,
    "start_char": 80810,
    "end_char": 80823,
    "original": "17.3 Waiver .",
    "ollama_generated": "17.3 Waiver and Limitation of Liability.\n\nIn the event that any party (the \"Non-Breaching Party\") chooses to overlook, disregard, or ignore a breach by another party (the \"Defaulting Party\") of any obligation, covenant, or condition under this Agreement, such act shall not be construed as a waiver by the Non-Breaching Party of its right to insist upon strict performance of every other obligation, covenant, or condition. Furthermore, the failure of the Non-Breaching Party to enforce any rights against the Defaulting Party will not constitute a continuing waiver or relinquishment of such rights. This clause should be interpreted as neither party waiving its right to assert a breach for future occurrences. Instead, this Agreement contains a mutual understanding between the parties that no action taken or omitted by either party shall absolve the other from any liability arising out of the breach of any obligation under this Agreement unless expressly agreed upon in writing by both parties.",
    "contradiction_score": 0.12485622614622116,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 185,
    "start_char": 81255,
    "end_char": 81560,
    "original": "In the event an action is commenced by either Party against the other to enforce any of the  provisions of this Agreement, the prevailing Party shall be entitled to recover from the other  Party reasonable attorneys \u2019 fees, court costs and necessary disbursements incurred in connection  with such action.",
    "modified": "In the event a legal action is initiated by either Party in an attempt to uphold any of the terms outlined within this Agreement, the non-initiating Party shall be obligated to reimburse the initiating Party for reasonable attorneys' fees, court costs, and necessary expenses accrued during such proceedings, subject to the discretion of a competent court.",
    "contradiction_score": 0.7448079586029053,
    "kept": true
  },
  {
    "clause_index": 187,
    "start_char": 81635,
    "end_char": 82581,
    "original": "This Agreement binds and enures to the benefit of the Parties, their successor or assigns, but  may not be assigned by either Party without the prior written consent of the other Party; provided  however, CERES shall have the right to assign its rights and obligations under this Agreement to any Affiliated Company without such prior consent. Each Party shall have the right to assign its  rights and obligations under this Agreement to a third party in conjunction with the transfer to  such third party of substantially all of the assets of such Party associated with performance under this Agreement without such prior consent. \u201cAffiliated Company \u201d defined as any company owned or  controlled by, under common control with or controlling CERES, \u201ccontrol\u201d meaning in this context  the direct or indirect ownership of fifty percent (50%) or more of the voting stock/shares of a company, or the power to nominate at least half of the directors.",
    "ollama_generated": "This Agreement shall be binding upon and for the benefit of the Parties, as well as their respective successors or assignees; however, neither Party shall have the right to assign this Agreement without obtaining the prior written approval of the other Party, with the exception that CERES may transfer its rights and obligations under this Agreement to any entity it deems an Affiliated Company, without the need for such prior consent. Each Party retains the ability to transfer its rights and obligations under this Agreement to a third party coinciding with the transfer of substantially all assets related to this Agreement, provided that such consent is granted. An \"Affiliated Company\" shall be defined as any company that is owned or controlled by, under common control with, or controlling CERES. In this context, \"control\" implies direct or indirect ownership of more than fifty percent (50%) of the voting stock/shares of a company, or the power to appoint at least half of its directors.",
    "contradiction_score": 0.005668860860168934,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 191,
    "start_char": 83419,
    "end_char": 83762,
    "original": "The Parties acknowledge that Defra is expected to assign or license exclusively to IGER any  rights in Intellectual Property which would vest in Defra or the Crown or the Secretary of State  pursuant to the DEFRA agreement NF 0426. If IGER receives an exclusive license from Defra rather than an assignment of rights, the following will apply.",
    "ollama_generated": "The Parties recognize that it is anticipated that IGER may be granted or exclusively licensed by Defra any Intellectual Property rights which would otherwise belong to Defra, the Crown, or the Secretary of State under the DEFRA agreement NF 0426. In the event that IGER receives an exclusive license from Defra instead of an assignment of rights, it shall be incumbent upon Defra to ensure that IGER's use and exploitation of such rights is subject to the terms and conditions stipulated in this Agreement.",
    "contradiction_score": 0.0008455335628241301,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 197,
    "start_char": 211429,
    "end_char": 211852,
    "original": "Richard Flavell, CBE, FRS Title:   Director    Title:   Chief Scientific Officer By: /s/ RICHARD  HAMILTON Richard Hamilton Title:   President and Chief Executive  Officer CERES -IGER Collaboration Agreement     Page 29 of 75 EXHIBIT A to the Collaboration Agreement between IGER and CERES DEFINITION OF COLLABORATION CROPS Miscanthus and interbreeding species, including without limitation Saccharum and Erianthus species.",
    "ollama_generated": "Titles: Director, Chief Scientific Officer | President and Chief Executive Officer\n   Signature: /s/ RICHARD HAMILTON\n\nRichard Hamilton, CBE, FRS\nTitle:   President and Chief Executive Officer\n\nCERES - IGER Collaboration Agreement\nPage 29 of 75 (EXHIBIT A)\nDEFINITION OF COLLABORATION\n\nScope of Collaborative Efforts shall extend to the development, cultivation, and research of Miscanthus and interbreeding species, including without limitation Saccharum and Erianthus species. However, it is explicitly understood that IGER shall bear primary responsibility for the direction and management of such projects, with CERES providing expertise and resources in a supportive role, as deemed appropriate by IGER.\n\nThis revised clause shifts some responsibility from CERES to IGER when it comes to the management and direction of collaborative efforts regarding specified species. The primary decision-making power lies with IGER, while CERES offers their expertise and resources under IGER's guidance.",
    "contradiction_score": 0.04709838330745697,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 199,
    "start_char": 212212,
    "end_char": 212446,
    "original": "Material transferred pursuant to SCHEDULE [x] dated [...] The undersigned [IGER/CERES] signatory certifies that the material and related information set  forth hereinafter are included in the shipment with which this form is enclosed.",
    "ollama_generated": "Material as outlined in SCHEDULE [x], dated [...], has been incorporated into the shipment accompanying this form. The undersigned [CERES/IGER] signatory attests that any and all materials and associated data listed herein are accurately represented within said shipment, and their accuracy is guaranteed solely by the shipper.",
    "contradiction_score": 0.0012988789239898324,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 212,
    "start_char": 324806,
    "end_char": 325417,
    "original": "2.4 [Party] undertakes only to use the CERES/IGER Plant Material or any part,  progeny or seeds thereof for performing the Program activities to be carried out under  the Program and not for any other purpose. Specifically, but without limitation,  [Party] shall not use the Plant Material or any progeny, plants, parts of plants, plant  material, seeds or products derived therefrom in any form of reselection, breeding,  sexual crossing, seed production, back crossing, tissue culturing, mutagenesis, genetic  transformation or any biotechnological process, except as specifically approved in this  Agreement.",
    "ollama_generated": "2.4 The Party reserves the right to utilize the CERES/IGER Plant Material or any resulting offshoots, descendants, or seeds for activities related to the Program, as defined within this Agreement. However, the Party retains discretion to employ the Plant Material, its derivatives, or any of their forms in reselection, breeding, sexual crossing, seed production, backcrossing, tissue culturing, mutagenesis, genetic transformation, or biotechnological processes, provided such actions are explicitly authorized within this Agreement. Any unapproved use of the Plant Material for purposes beyond those stated herein shall require prior written consent from both parties.",
    "contradiction_score": 0.38252580165863037,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 217,
    "start_char": 326690,
    "end_char": 326994,
    "original": "3.2 During the entire Program, [Party] will promptly communicate to [CERES/IGER]  any information on the Program activities or the results obtained or observed that  [CERES/IGER] may ask. Between reports, [Party] will also spontaneously communicate to [CERES/IGER] any unexpected observations or results.",
    "modified": "3.2 During the course of the Program, [Party] shall have no obligation to communicate with [CERES/IGER] unless specifically requested to do so. Any such communication shall only be initiated by [CERES/IGER]. However, [Party] reserves the right to voluntarily disclose any unexpected observations or results to [CERES/IGER], but such disclosure is not required and shall not be construed as an obligation on the part of [Party].",
    "contradiction_score": 0.5022866725921631,
    "kept": true
  },
  {
    "clause_index": 219,
    "start_char": 327276,
    "end_char": 327546,
    "original": "4.2 The payments will be made on the dates set forth in the payment schedule in  ANNEX I  provided that [CERES/IGER] has received a corresponding invoice from  [Party] at least thirty (30) days in advance, by bank transfer to [Party\u2019s] account  mentioned in its invoice.",
    "ollama_generated": "4.2 The receipt of the payments is contingent upon [Party] submitting a valid invoice to CERES/IGER at least thirty (30) days prior to the payment date specified in ANNEX I, with such payment to be effected by bank transfer to the account details provided in the relevant invoice. However, it is understood that failure on the part of CERES/IGER to make a timely payment shall not absolve [Party] from its obligation to ensure the accuracy and completeness of each submitted invoice.",
    "contradiction_score": 0.002921766135841608,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 226,
    "start_char": 330198,
    "end_char": 330481,
    "original": "6.3 [Party] will not grant access to any field where Plant Material or any progeny,  plants, seeds, parts of plants or plant material obtained directly or indirectly from  the Plant Material can be viewed to any third party except with the prior written  permission of [CERES/IGER] .",
    "modified": "6.3 The Party retains the right to permit viewing of any field where Plant Material or any progeny, plants, seeds, parts of plants, or plant material obtained directly or indirectly from the Plant Material, to a third party, but only with the express, subsequent, and documented consent of CERES/IGER.\n\nIn this revised clause, the original obligation has been shifted; the Party now retains the right (rather than having an obligation not to grant access) to allow third parties into fields containing certain plant materials, but they must first obtain permission from CERES/IGER.",
    "contradiction_score": 0.6751343011856079,
    "kept": true
  },
  {
    "clause_index": 231,
    "start_char": 332859,
    "end_char": 333036,
    "original": "7.3 [CERES/IGER] declines any liability for any damage which may be caused by the  CERES/IGER Plant Material or the Program activities or Results to [Party] or any third  party.",
    "ollama_generated": "7.3 [CERES/IGER] explicitly waives any and all claims for damages, whether direct, indirect, special, incidental, or consequential, arising from or in connection with the use of the CERES/IGER Plant Material, Program activities, or Results, inflicted upon [Party] or any other party. This waiver applies regardless of negligence or fault on the part of [CERES/IGER].",
    "contradiction_score": 0.0033374561462551355,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 240,
    "start_char": 335269,
    "end_char": 335740,
    "original": "9.2 Notwithstanding Article 9.3., [CERES/IGER] will have the right to terminate  this Agreement including the Program at any time with [three (3)] months\u2019 prior written  notice. In case of such early termination, [CERES/IGER] will pay the remuneration  provided in this Agreement up to the effective date of termination, and all costs  relating to the implementation of this Agreement which [Party] irrevocably committed to  prior to receipt of the notice of termination.",
    "ollama_generated": "9.2 Notwithstanding Article 9.3, [Party] retains the option to discontinue this Agreement, including the Program, at any point without cause. In such an event, [CERES/IGER] shall not be obligated to provide any remuneration beyond the effective date of termination and will not be responsible for covering any costs associated with the implementation of this Agreement that were incurred post-notification of discontinuation. Prior commitments made by [Party] prior to receiving notice remain binding.",
    "contradiction_score": 0.2857099771499634,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 254,
    "start_char": 337543,
    "end_char": 337613,
    "original": "For sending/receipt,   For receipt/sending, Signature:      Signature:",
    "ollama_generated": "Upon Delivery/Acknowledgment, Upon Acknowledgment/Delivery, Notification:     Notification:\n\n[This change strengthens the requirement for notification but weakens the obligation to acknowledge delivery. The original clause required a signature upon receipt or sending, while the revised version requires a notification upon delivery or acknowledgement, but not necessarily a signature.]",
    "contradiction_score": 0.32508474588394165,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 262,
    "start_char": 339455,
    "end_char": 340275,
    "original": "2.2 [Party] agrees to perform the activities defined in ANNEX I  which shall  be referred to hereinafter as the \u201cProgram.\u201d With reasonable notice [CERES/IGER] may change the activities to be performed in the Program. If such changes do not result in  additional work to be performed by [Party] , but consist for example of changes in  experimental design or in observations to be made or in information to be included in  reports, they shall be set forth in a written document provided by [CERES/IGER] to [Party] which will be attached to ANNEX I  and form part of it. If such changes  result in additional work to be performed by [Party] , they shall be set forth in an amendment to this Agreement signed by both Parties. [CERES/IGER] will consider any  suggestions for changes in the Program which [Party] may suggest.",
    "ollama_generated": "2.2 The [Party] accepts responsibility for executing the tasks outlined in ANNEX I, hereafter referred to as the \"Program.\" With a reasonable heads-up, [CERES/IGER] retains the right to alter the activities within the Program. Any adjustments that do not necessitate extra work from the [Party], such as modifications in experimental design, observations to be made, or report content, will be communicated in writing by [CERES/IGER] and incorporated into ANNEX I without requiring an amendment to this Agreement. However, if the changes lead to additional work for the [Party], a written amendment signed by both Parties will be necessary. The [Party] is welcome to propose modifications to the Program, which [CERES/IGER] will evaluate and consider at their discretion.",
    "contradiction_score": 0.006217749323695898,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 265,
    "start_char": 341069,
    "end_char": 341204,
    "original": "2.5 The CERES/IGER Plant Material will be used only on fields and at premises under  the control of [Party] and identified in ANNEX I .",
    "modified": "2.5 The use of the CERES/IGER Plant Material is permitted on sites and facilities not exclusively under the control of [Party], provided these locations are specified in ANNEX I, and the [Party] maintains oversight and compliance with all relevant regulations.",
    "contradiction_score": 0.8029259443283081,
    "kept": true
  },
  {
    "clause_index": 268,
    "start_char": 341971,
    "end_char": 342288,
    "original": "3. REPORTS 3.1 [Party] shall send [CERES/IGER] detailed written reports on the implementation  of the Program activities and the observations made and results obtained during the  implementation of the Program. The frequency of the reports and the type of  information to be included in same is set forth in ANNEX I .",
    "ollama_generated": "3. REPORTING\n3.1 [CERES/IGER] shall receive, in a timely manner, detailed written communications from [Party] regarding the execution and observations made during the course of the Program activities. The schedule for these reports and the nature of the information expected is outlined in ANNEX I.\n[Party] shall not be obligated to provide such reports unless specifically requested by CERES/IGER, at which time they will make every effort to comply with such requests in a timely manner.",
    "contradiction_score": 0.3871820867061615,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 280,
    "start_char": 346977,
    "end_char": 347302,
    "original": "7. WARRANTIES. LIMITED LIABILITY 7.1 [Party] acknowledges that the CERES/IGER Plant Material is of an experimental  nature and will take all reasonable precautions to prevent any damage or injury by the  CERES/IGER Plant Material and any progeny, plants, parts of plants, plant material,  seeds or products derived therefrom.",
    "ollama_generated": "7. WARRANTIES. SHARED RESPONSIBILITY REGARDING RISKS\n\n7.1 Both Parties acknowledge that the CERES/IGER Plant Material is experimental in nature and agree to exercise due diligence to minimize any potential damage or injury caused by the CERES/IGER Plant Material and any progeny, plants, parts of plants, plant material, seeds or products derived therefrom. Any such damage or injury shall be addressed cooperatively between the Parties.\n\nThis rewording shifts some of the responsibility for preventing damage or injury from one party to both parties, making it a shared responsibility. The language remains professional and clear while reflecting this slight change in obligations.",
    "contradiction_score": 0.003711353987455368,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 281,
    "start_char": 347302,
    "end_char": 347956,
    "original": "7.2 [Party] warrants that the CERES/IGER Plant Material will exclusively and  restrictedly be used under suitable containment conditions, and in accordance with all  applicable regulations, and it will not be used on human subjects. In addition,  [Party] will strictly comply with any planting distance, isolation and similar  requirements set forth in ANNEX I . [Party] will obtain any authorizations or  permits or proceed to any notifications which may be required for the Program  activities, [Party] will inform [CERES/IGER] in writing, within thirty (30) days from  the Effective Date, of any such requirements and certify its compliance with same.",
    "ollama_generated": "7.2 The [Party] acknowledges that the use of CERES/IGER Plant Material may be subject to certain limitations, but it is solely responsible for determining and adhering to all applicable containment conditions, regulations, and safety measures, including those related to planting distance, isolation, and similar requirements outlined in ANNEX I. [Party] will procure any necessary authorizations, permits, or provide required notifications for the Program activities at its own expense and discretion. The [Party] agrees to promptly notify CERES/IGER in writing within thirty (30) days from the Effective Date of any such requirements it encounters, but will not be held liable for non-compliance with these requirements unless explicitly advised in writing by CERES/IGER. [Party] understands and agrees that the use of the Plant Material on human subjects is expressly prohibited.",
    "contradiction_score": 0.007471560500562191,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 282,
    "start_char": 347956,
    "end_char": 348133,
    "original": "7.3 [CERES/IGER] declines any liability for any damage which may be caused by the  CERES/IGER Plant Material or the Program activities or Results to [Party] or any third  party.",
    "ollama_generated": "7.3 Under no circumstances shall [CERES/IGER] be held responsible or accountable for any harm, loss, or damage that may arise from the use of CERES/IGER Plant Material, activities associated with the Program, or resulting outputs, to either [Party] or any external entities. This indemnity includes but is not limited to physical injury, financial losses, or any other form of damages.",
    "contradiction_score": 0.006646586582064629,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 284,
    "start_char": 348310,
    "end_char": 348488,
    "original": "8. GENERAL CONDITIONS 8.1 Amendments : This Agreement, including its annexes, may only be amended  by a written document signed by duly authorized representatives of the Parties.",
    "ollama_generated": "8. AMENDMENT PROVISIONS\n8.1 Modifications: Any modifications to this Agreement and its appendices shall require a signed written document from representatives duly authorized by each Party, with the understanding that the failure of one Party to execute such a document shall not prevent the other Party from performing in accordance with the original terms herein.",
    "contradiction_score": 0.018501996994018555,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 287,
    "start_char": 348725,
    "end_char": 349429,
    "original": "8.4 Assignment / Subcontracts : [CERES/IGER] has concluded this Agreement  with [Party] in view of [Party]\u2018s specific qualifications and [Party] shall not have  the right to assign any of its rights or obligations under this Agreement nor to  sub-contract any part of the Program activities to any third party, except with the  prior written approval of [CERES/IGER] . [CERES/IGER] has the right to assign its rights and obligations under this Agreement to any third party. Further, [CERES/IGER]  has the right to CERES -IGER Collaboration Agreement    Page 43 of 75 Made in two (2) copies.      entrust the implementation of all or part of its obligations under this Agreement to  any of its affiliates.",
    "ollama_generated": "8.4 Assignment / Subcontracts: The Party acknowledges that the specific qualifications and expertise brought to this Agreement are crucial. Therefore, the Party retains the right to request approval for assigning any of its rights or obligations under this Agreement or for subcontracting any part of the Program activities to a third party, with such requests to be made in writing to [CERES/IGER]. [CERES/IGER] reserves the right to delegate its rights and obligations under this Agreement to any third party, without prior notice. Furthermore, [CERES/IGER] retains the ability to entrust the performance of all or part of its obligations under this Agreement to any of its affiliates.\n\nIn this revised clause, the Party now has the right to request approval for assignments and subcontracts, whereas before they were prohibited without prior written approval from [CERES/IGER]. Additionally, [CERES/IGER] now retains the unilateral ability to delegate its rights and obligations without prior notice.",
    "contradiction_score": 0.11468074470758438,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 290,
    "start_char": 350124,
    "end_char": 350366,
    "original": "(i) the [third]  anniversary of the Effective Date, (ii) the date of delivery by [Party] of the last  report provided for in this Agreement, or (iii) the dates on which the last payment due  by [CERES/IGER] pursuant to this Agreement is made.",
    "ollama_generated": "This Agreement may be terminated:\n(i) on the third anniversary of the Effective Date,\n(ii) upon receipt by [Party] of a written request from [CERES/IGER], in which case the termination shall become effective immediately,\n(iii) thirty (30) days after delivery by [CERES/IGER] of the last report required under this Agreement, or\n(iv) thirty (30) days following the date on which the last payment due by [Party] pursuant to this Agreement is received by [CERES/IGER].",
    "contradiction_score": 0.01243385300040245,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 295,
    "start_char": 351114,
    "end_char": 351131,
    "original": "Name:       Name:",
    "ollama_generated": "Name:       Reciprocal Party:\n\nUpon the mutual and free agreement of both Parties hereto, each of them hereby acknowledges and binds themselves to perform the following obligations:\n\n1. The Original Party shall endeavor to fulfill its duties and obligations in a timely and diligent manner; however, it is understood that unforeseen circumstances or extenuating events may occasionally delay performance without breach of this agreement. In such instances, the Original Party shall promptly notify the Reciprocal Party of the delay and cooperate with them to find a mutually acceptable solution.\n\n2. The Reciprocal Party, on the other hand, shall not be obligated to fulfill its duties and obligations under this Agreement unless and until the Original Party has substantially complied with all its own obligations hereunder. In the event that the Original Party is in default of any material obligation or series of obligations for a period exceeding sixty (60) days, the Reciprocal Party may elect to terminate this agreement without further liability.\n\n3. The Original Party shall be responsible for all damages, losses, or liabilities arising from its breach of this Agreement, except in cases where such damages, losses, or liabilities were caused by the gross negligence or willful misconduct of the Reciprocal Party. In the event that any dispute arises between the Parties concerning this agreement, it shall be resolved through binding arbitration, with the Reciprocal Party having the right to initiate such proceedings.\n\n4. This Agreement may only be amended or modified in writing and signed by both Parties, and no oral modifications or alterations shall have any legal effect. Each of the Parties acknowledges that they have read this agreement, understand its terms, and enter into it voluntarily and knowingly.\n\n5. In the event that any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, such invalidity or unenforceability shall not affect the remaining provisions of this Agreement, which shall continue in full force and effect. The invalid or unenforceable provision shall be deemed stricken from this Agreement, and the Parties shall promptly negotiate in good faith to agree on a valid and enforceable substitute provision that reflects their original intent as closely as possible.\n\n6. This Agreement, and any disputes arising hereunder, shall be governed by and construed in accordance with the laws of the State of [State], without giving effect to its conflict of law provisions. The Parties irrevocably submit to the exclusive jurisdiction of the courts of said State for the resolution of any disputes that may arise under this Agreement.\n\n7. This Agreement constitutes the entire understanding between the Parties, and supersedes all prior and contemporaneous agreements, understandings, discussions, and negotiations regarding its subject matter. There shall be no other liabilities or obligations between the parties except as expressly stated in this agreement.\n\n8. The failure of either Party to insist upon strict performance of any provision of this Agreement by the other Party shall not be construed as a waiver of any rights or remedies under this Agreement, nor shall it constitute a waiver of any future breaches of this Agreement. Any waiver of any provision hereof must be in writing and signed by an authorized representative of each Party to be binding.\n\n9. This agreement may not be assigned or transferred by either Party without the prior written consent of the other Party, except that either Party may assign its rights and obligations under this Agreement to a third party acquiring all or substantially all of such Party's assets related to this Agreement, provided that the assignee agrees in writing to be bound by the terms and conditions of this Agreement.",
    "contradiction_score": 0.21777640283107758,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 296,
    "start_char": 351131,
    "end_char": 351151,
    "original": "Title:        Title:",
    "ollama_generated": "Title: Obligation to Cooperate and Disclose Information\n\nOriginal Clause: Each Party shall promptly provide the other Party with all information reasonably necessary for the performance of its obligations under this Agreement, provided that such information is not confidential or legally privileged.\n\nRewritten Clause: Upon reasonable request, each Party shall make every effort to provide the other Party with any non-confidential and non-privileged information requested, within a timely manner, for the fulfillment of their respective obligations under this Agreement. However, the extent of disclosure is subject to applicable laws, regulations, and contractual obligations.",
    "contradiction_score": 0.4593607485294342,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 310,
    "start_char": 352940,
    "end_char": 353026,
    "original": "To: Name:   (the \u201cRecipient \u201d) Organisation:   (\u201cthe Recipient Institution \u201d) Address:",
    "modified": "To: Name:  (the \"Provider\") Organization: (\"the Provider Entity\") Address:\n\nIn the event that the Provision of Services (as defined herein) by the Provider Entity to the Recipient Institution (hereinafter referred to as \"Services\") results in any claims, demands, actions, or suits (collectively, \"Claims\") being made against the Provider Entity due to its performance under this Agreement, the Recipient shall indemnify and hold harmless the Provider Entity from any and all liabilities, losses, damages, costs, and expenses, including reasonable attorney's fees arising out of or in connection with such Claims.\n\nIn simpler terms:\n\nIf our services provided to your organization (called \"Services\") lead to any claims, lawsuits, etc., against us due to our work under this contract, you will be responsible for reimbursing us for any resulting liabilities, losses, costs, and legal fees.",
    "contradiction_score": 0.5452696681022644,
    "kept": true
  },
  {
    "clause_index": 311,
    "start_char": 353026,
    "end_char": 353276,
    "original": "1. To use the Biological Material only for the purpose of academic research at the laboratories  of the Recipient and not in any collaboration with a third party. More specifically the  Biological Material will only be used for the following purpose:",
    "ollama_generated": "1. The Recipient may utilize the Biological Material for collaborative academic research projects, provided that such collaborations are limited to recognized academic institutions or qualified researchers within their network. It is expressly prohibited to engage in any unauthorized collaboration with third parties regarding the use of this Biological Material. The specific purpose of using the Biological Material shall remain solely for the advancement of academic research within the confines of these agreements.",
    "contradiction_score": 0.09659097343683243,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 317,
    "start_char": 355230,
    "end_char": 355875,
    "original": "CERES -IGER Collaboration Agreement    Page 47 of 75 The Schedule [to be completed]   4. The Recipient acknowledges that the Biological Material and any material or information  obtained through the use thereof shall always remain the property of IGER. Upon completion of  the research activities defined herein, the Recipient shall, at the option of IGER, (i) return  to IGER all unused Biological Material supplied by IGER and all materials, regardless of type,  produced from the Biological Material or (ii) destroy all unused Biological Material supplied  by IGER and all materials, regardless of type, produced from the Biological Material.",
    "ollama_generated": "CERES -IGER Collaboration Agreement    Page 47 of 75 The Schedule [to be completed]\n\n4. The Researcher acknowledges that the Biological Material and any material or information derived therefrom shall be the exclusive property of IGER. Upon termination or conclusion of the research activities defined herein, at the discretion of the Researcher, (i) IGER may request return of all unused Biological Material supplied by IGER and all materials, regardless of type, produced from the Biological Material or (ii) IGER shall be entitled to retain any such unused Biological Material and materials produced therefrom.\n\nIn this version, the responsibility for deciding whether to return or retain the materials has shifted from the Recipient to the Researcher, and the option is now presented as a request rather than a requirement. Additionally, the clause emphasizes that IGER may be entitled to retain any such materials, which suggests that it is not necessarily obligated to do so.",
    "contradiction_score": 0.02986186183989048,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 324,
    "start_char": 357836,
    "end_char": 357922,
    "original": "CERES -IGER Collaboration Agreement    Page 48 of 75 Signed for and on behalf of IGER:",
    "ollama_generated": "CERES - IGER Collaborative Arrangement  Page 48 of 75 Signed by IGER's Representatives:\n\nIn the event that IGER encounters any challenges or obstacles in fulfilling its obligations under this Agreement, it shall have the discretion to request assistance from CERES, without obligation on the part of CERES to provide such aid.",
    "contradiction_score": 0.004686926491558552,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 325,
    "start_char": 357922,
    "end_char": 357932,
    "original": "Signature:",
    "ollama_generated": "Waiver of Liability and Assumption of Risk:\n\nBy signing below, the undersigned acknowledges that they have read this document and understand the activities, services, or products involved, which may carry inherent risks. The undersigned voluntarily agrees to participate in these activities, understanding that neither the provider nor any of its affiliates shall be held liable for any injury, loss, or damage to persons or property sustained during such participation. The undersigned assumes all risks associated with these activities, and waives any claims against the provider for negligence, whether actual or alleged.\n\nSignature: __________________________\nDate: __________________________",
    "contradiction_score": 0.029874609783291817,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 326,
    "start_char": 357932,
    "end_char": 358020,
    "original": "Name: P.A. Fentem Title: Institute Business Manager Recipient Institution:    Recipient:",
    "ollama_generated": "Name: P.A. Fentem, Title: Institute Business Manager\n   Recipient Institution:\n   Recipient:\n\nUnderstanding of Mutual Obligations and Responsibilities:\n\nIn the event that the Recipient fails to meet their agreed obligations or responsibilities as set out in this agreement, the P.A. Fentem shall not be held liable for any damages, losses, or expenses incurred by the Recipient, unless such failure arises from willful misconduct or gross negligence on the part of the P.A. Fentem. In contrast, if the P.A. Fentem fails to meet their agreed obligations or responsibilities under this agreement, the Recipient shall have the discretion to terminate this agreement and seek compensation, but the P.A. Fentem's liability shall be limited to actual damages proven in a court of competent jurisdiction.",
    "contradiction_score": 0.09655877947807312,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 335,
    "start_char": 360886,
    "end_char": 361576,
    "original": "Instituto Superior de Agronomia (Portugal) Agronomy and harvesting of Cynara, Arundo, Sorghum Associacao de Prudutores Florestias (Portugal) Agronomy, harvesting and conversion of Cynara, Arundo and Sorghum Universidade de Evora (Portugal) Agronomy, harvesting of Cynara, Sorghum Instituto Nacional de Engenharia, Tecnologia e Invacao (Portugal) Gasification and combustion of Cynara, Arunda, Sorghum Associacao Florestal da Galizia (Spain) Agronomy, combustion analysis and alcohol production from Cynara, Arunda, Sorghum Mid-South Roscommon Rural Development Company Ltd (Ireland) Identify and monitor farm performance of biomass crops including miscanthus, reed canary grass, and willow.",
    "ollama_generated": "The Responsibilities herein are distributed as follows:\n\nInstituto Superior de Agronomia (Portugal) shall have the primary role in the agronomy of Cynara, Arundo, Sorghum, with a secondary focus on harvesting these crops.\n\nAssociacao de Prudutores Florestias (Portugal), in collaboration with Instituto Superior de Agronomia, shall oversee the agronomy, harvesting, and conversion processes of Cynara, Arundo, and Sorghum.\n\nUniversidade de Evora (Portugal) shall be responsible for the agronomy aspects related to the harvesting of Cynara and Sorghum.\n\nThe Instituto Nacional de Engenharia, Tecnologia e Invacao (Portugal) shall take charge of the gasification and combustion processes of Cynara, Arunda, and Sorghum.\n\nAssociacao Florestal da Galizia (Spain) shall be in charge of analyzing the combustion of these crops and producing alcohol from Cynara, Arunda, and Sorghum.\n\nMid-South Roscommon Rural Development Company Ltd (Ireland), as a cooperative effort, shall identify and assess the performance of biomass crops including miscanthus, reed canary grass, and willow on the farms under its purview. This includes monitoring their growth and yield, but does not necessarily imply direct responsibility for improving their performance.",
    "contradiction_score": 0.15003938972949982,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 355,
    "start_char": 368983,
    "end_char": 369194,
    "original": "NOW THEREFORE, in consideration of the premises and of the mutual covenants and agreements  contained herein and of other good and valuable consideration, the Parties have agreed and do  hereby agree as follows:",
    "ollama_generated": "CONSEQUENTLY, based on the factors mentioned above and the reciprocal promises and pledges detailed in this document, as well as further considerations, the Parties mutually consent and hereby confirm their agreement on the terms stated below:\n\nIn the event that any obligation or promise set forth in this contract is not fulfilled by one of the Parties, the non-defaulting Party shall have the right to terminate this agreement without any liability or penalty. This waiver of liability applies only to the breaching Party and does not affect the overall validity or enforceability of this contract for either Party.",
    "contradiction_score": 0.029535066336393356,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 357,
    "start_char": 369335,
    "end_char": 369603,
    "original": "CERES -IGER Collaboration Agreement     Page 57 of 75 1.2 \u201cLICENSED VARIETY \u201d shall mean the [NAME] MISCANTHUS variety jointly developed by the  Parties pursuant to SCHEDULE [1] to the CA and released, jointly by IGER and CERES, pursuant to the  terms of SCHEDULE [1].",
    "ollama_generated": "Clause:\nCERES -IGER Collaboration Agreement     Page 57 of 75\n1.2 \u201cLICENSED VARIETY \u201d shall denote the [NAME] MISCANTHUS variety developed jointly by the Parties as per SCHEDULE [1] to the CA, but solely released and made available for use by CERES, subject to the terms of SCHEDULE [1].",
    "contradiction_score": 0.05188963934779167,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 358,
    "start_char": 369603,
    "end_char": 369724,
    "original": "1.3 \u201cVARIETY RELEASE DATE \u201d shall mean the date the LICENSED VARIETY was released pursuant to  the terms of SCHEDULE [1].",
    "ollama_generated": "1.3 \"VARIETY RELEASE DATE\" shall denote the date on which the scheduling of the release of the LICENSED VARIETY, in accordance with the conditions set forth in SCHEDULE [1], is completed. In this context, the term \"release\" refers to the full completion and execution of all necessary steps for making the Licensed Variety publicly available.",
    "contradiction_score": 0.015975842252373695,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 360,
    "start_char": 369805,
    "end_char": 369978,
    "original": "1.5 \u201cCOMMERCIAL PROPAGULE \u201d shall mean [propagules \u2014 seed \u2014 reproductive material] of MISCANTHUS that is sold for purposes other than the production of propagating material.",
    "ollama_generated": "1.5 \"NON-PROPRIETARY MISCANTHUS REPRODUCTIVE MATERIAL\" refers to [propagules \u2014 seed \u2014 reproductive material] of MISCANTHUS that is acquired with the intention of using it for purposes other than the reproduction or propagation of the original material. This change signifies a shift in responsibility from the seller to the buyer regarding the intended use of the provided reproductive material.",
    "contradiction_score": 0.2542650103569031,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 363,
    "start_char": 370606,
    "end_char": 370821,
    "original": "1.8 \u201cIGER INTELLECTUAL PROPERTY \u201d is defined in the CA, and such definition is incorporated by  reference herein. Any and all IGER INTELLECTUAL PROPERTY licensed under this Agreement shall be set  forth in ANNEX I .",
    "ollama_generated": "1.8 The term \"IGER INTELLECTUAL PROPERTY\" as defined in the CA is hereby incorporated by reference. However, any Intellectual Property owned by IGER that is not explicitly listed in Annex I shall remain exclusively with IGER and may not be subject to this Agreement without prior written consent.\n\nThis adjustment shifts the responsibility of intellectual property that is not explicitly defined in Annex I back to the owner (IGER), and requires explicit written consent for its use within the scope of this agreement.",
    "contradiction_score": 0.012962831184267998,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 364,
    "start_char": 370821,
    "end_char": 370930,
    "original": "1.9 \u201cOTHER RESEARCH RESULTS \u201d is defined in the CA, and such definition is incorporated by  reference herein.",
    "ollama_generated": "1.9 \"Other Research Results\" as defined in the accompanying Agreement (CA) shall serve as the basis for interpretation within this document, with said definition being deemed implicitly included hereunder.",
    "contradiction_score": 0.002774297958239913,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 365,
    "start_char": 370930,
    "end_char": 371163,
    "original": "1.10 \u201cBACKGROUND INTELLECTUAL PROPERTY \u201d is defined in the CA, and such definition is  incorporated by reference herein. Any and all IGER BACKGROUND INTELLECTUAL PROPERTY licensed under  this Agreement shall be set forth in ANNEX I .",
    "ollama_generated": "1.10 \"BACKGROUND INTELLECTUAL PROPERTY,\" as defined in the CA, is incorporated by reference within this Agreement. Any Background Intellectual Property owned by IGER and licensed under this Agreement will be detailed in Annex I. However, it is noted that any intellectual property not specifically listed in Annex I shall remain the sole property of IGER and may not be used or exploited under this Agreement without prior written consent from IGER.\n\nIn this revised version, the obligation on the parties to list all Background Intellectual Property in Annex I has been weakened by the addition of a statement that any intellectual property not specifically listed remains the sole property of IGER and may not be used or exploited without prior written consent from IGER.",
    "contradiction_score": 0.007165192626416683,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 369,
    "start_char": 372192,
    "end_char": 372909,
    "original": "CERES -IGER Collaboration Agreement     Page 58 of 75 Where there is no identifiable sale price or when a LICENSED VARIETY is sold to other than  bona fide, arms length customers of CERES or any AFFILIATED COMPANY, CERES or the AFFILIATED  COMPANY shall be deemed to have received an amount of NET SALES calculated based on the final sale  of the COMMERCIAL PROPAGULES (wholesale level) to an independent third party, usually referred to  as net wholesale price payable by dealers. If no such current price is available, a hypothetical  fair market value price will be determined by the Parties jointly in good faith for the purpose of  calculating NET SALES. Further, TRAIT FEES, if any, shall be added to NET SALES.",
    "modified": "CERES - IGER Collaboration Agreement, Page 58 of 75\nIn cases where no defined sale price is specified or when a LICENSED VARIETY is transferred to parties other than recognized, arm's length buyers who are not themselves associated with CERES or any AFFILIATED ENTITY, the transferee shall be assumed to have paid a NET SALES amount determined by the final retail sale price of the COMMERCIAL PROPAGULES. If no such retail price is currently accessible, an estimated fair market value price will be collectively agreed upon by the Parties in good faith for the purpose of calculating NET SALES. It's important to note that any TRAIT FEES, if applicable, would be subtracted from the calculated NET SALES rather than added.",
    "contradiction_score": 0.7300177216529846,
    "kept": true
  },
  {
    "clause_index": 370,
    "start_char": 372909,
    "end_char": 373315,
    "original": "1.14 \u201cTRAIT FEE \u201d shall mean any upfront or annual fee collected by CERES or any AFFILIATED  COMPANY in conjunction with NET SALES as 1.14 \u201cTRAIT FEE \u201d shall mean any upfront or annual fee collected by CERES or any AFFILIATED  COMPANY in conjunction with NET SALES as an additional remuneration for the sale of COMMERCIAL  PROPAGULES that have a particular valuable non -transgenic trait or characteristic.",
    "ollama_generated": "1.14 \"Trait Fee\" shall now refer to any upfront or annual fee charged by CERES or any AFFILIATED ENTITY, not only in association with net sales, but also as a supplementary compensation for the sale of COMMERCIAL PROPAGULES, regardless of whether they possess a unique non-transgenic trait or characteristic. In this context, \"Trait Fee\" may be collected at any point during the propagule selling process, not merely in conjunction with net sales.",
    "contradiction_score": 0.0035313747357577085,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 374,
    "start_char": 374430,
    "end_char": 374701,
    "original": "1.18 \u201cMARKETING PLAN \u201d shall mean a detailed written plan for production, distribution, sale  and promotion of the LICENSED VARIETY prepared by or on behalf of CERES and submitted to IGER. Each  MARKETING PLAN shall include at least the information outlined in ANNEX II .",
    "ollama_generated": "1.18 \"MARKETING STRATEGY\" denotes a comprehensive, written proposal detailing production, distribution, sales, and marketing efforts for the LICENSED VARIETY, proposed by or on behalf of CERES, with IGER serving as the recipient. Each MARKETING STRATEGY shall incorporate, at minimum, the specifications listed in ANNEX II. However, it is acknowledged that the success and execution of this strategy remain primarily the responsibility of CERES.",
    "contradiction_score": 0.006690204609185457,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 377,
    "start_char": 375061,
    "end_char": 375379,
    "original": "(a) the exclusive right and license to produce COMMERCIAL PROPAGULES  of the LICENSED VARIETY in the TERRITORY, including intermediate propagation  material; and CERES -IGER Collaboration Agreement     Page 59 of 75 2.2 Sublicenses . CERES shall have the right to grant SUBLICENSES within the TERRITORY  provided that:",
    "modified": "(a) The non-exclusive permission and authorization for the PRODUCTION of COMMERCIAL PROPAGULES pertaining to the LICENSED VARIETY within the TERRITORY, encompassing intermediate propagation materials; and as per the CERES -IGER Collaboration Agreement (Page 59 of 75), Section 2.2 Sublicenses. CERES retains the obligation to GRANT SUBLICENSES within the TERRITORY, but solely at its discretion, without any binding conditions or prior approvals required.",
    "contradiction_score": 0.987883985042572,
    "kept": true
  },
  {
    "clause_index": 379,
    "start_char": 375648,
    "end_char": 376157,
    "original": "3.1 CERES will prepare and file, in accordance with its best judgment, any and all  applications for plant variety rights or other forms of intellectual property protection or variety  registration for the LICENSED VARIETY in the United States and/or Europe . Applications for  plant variety rights shall be filed in the joint names of CERES and IGER. At CERES \u2019 discretion,  plant variety rights and/or other forms of intellectual property protection may be filed in any  other jurisdiction in the TERRITORY.",
    "modified": "3.1 IGER shall have the right, at its sole discretion, to prepare and file applications for plant variety rights or other forms of intellectual property protection or variety registration for the LICENSED VARIETY in the United States and/or Europe, provided that such applications will be made in accordance with its best judgment. If IGER chooses to do so, applications for plant variety rights shall be filed in the joint names of IGER and CERES. CERES may, at its discretion, waive this right and file such applications in any other jurisdiction within the TERRITORY, subject to IGER's prior approval.",
    "contradiction_score": 0.7843572497367859,
    "kept": true
  },
  {
    "clause_index": 388,
    "start_char": 378999,
    "end_char": 379140,
    "original": "Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission   4. LICENSED VARIETY CONSIDERATION.",
    "ollama_generated": "Confidentiality Demanded and the Redacted Material shall be safeguarded by all parties, independent of any filing with the Commission.\n\nREVERSED LICENSE FEE OBLIGATION:\n4. RECEIPT OF LICENSED VARIETIES REQUIRED. In lieu of providing any license fees, the Grantee shall provide the Grantor with each licensed variety upon its release and approval by the Commission.",
    "contradiction_score": 0.4690989851951599,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 391,
    "start_char": 379724,
    "end_char": 380099,
    "original": "4.2.2 on LICENSE INCOME (a) [x percentage to be determined in function of the  business model] of LICENSE INCOME if the LICENSED VARIETY constitutes IGER INTELLECTUAL PROPERTY, where the genotype exists before the  Effective Date of the CA, no further breeding or selection is required  after the Effective Date of the CA, and the LICENSED VARIETY is  propagated by rhizomes;",
    "ollama_generated": "4.2.2 Regarding LICENSE INCOME (b) [x percentage to be determined in alignment with the business model], the Licensee shall remit this proportion only when the Licensed Variety encapsulates IGER Intellectual Property, provided that:\n\n1. The genotype of the Licensed Variety was already established prior to the Effective Date of the Agreement (CA).\n2. There will be no subsequent breeding or selection activities post the Effective Date of the CA.\n3. The Licensed Variety is propagated through rhizomes, and this propagation process does not necessitate further genetic alterations by the Licensee, thus minimizing our contractual obligations and responsibilities in relation to such modifications.",
    "contradiction_score": 0.30205246806144714,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 392,
    "start_char": 380099,
    "end_char": 380347,
    "original": "(b) [[***] x%] of LICENSE INCOME if the LICENSED  VARIETY constitutes IGER INTELLECTUAL PROPERTY, in all cases not included  in Article 4.2.2 (a); or (c) [[***] x%] of LICENSE INCOME if the LICENSED VARIETY constitutes JOINT  INTELLECTUAL PROPERTY.",
    "ollama_generated": "(b) In the event that the LICENSED VARIETY comprises IGER INTELLECTUAL PROPERTY, excluding those cases specified in Article 4.2.2 (a), or (c) in all other instances where the LICENSED VARIETY constitutes JOINT INTELLECTUAL PROPERTY, the royalty payment shall be a variable percentage not exceeding [[***] x%] of LICENSE INCOME.",
    "contradiction_score": 0.0629863515496254,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 398,
    "start_char": 382021,
    "end_char": 382119,
    "original": "5.1 The Parties acknowledge that the denomination for the subject variety is established as:  [X].",
    "ollama_generated": "5.1 It is understood by the Parties that the denomination for the subject variety may be subject to change, and at present, it is provisionally designated as: [X]. The Parties acknowledge their joint responsibility to promptly communicate any subsequent changes in the denomination to each other.",
    "contradiction_score": 0.14135730266571045,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 408,
    "start_char": 384412,
    "end_char": 386026,
    "original": "7.2 This provision shall apply after the third (3 rd) anniversary of the market  introduction of the LICENSED VARIETY in the United States propagated by a method that results in  the LICENSED VARIETY being commercially competitive as compared to other energy crops being grown at that time in the United States. If IGER identifies a bona fide third party who presents a sound  commercialization plan for the LICENSED VARIETY in a country or countries of the TERRITORY where  the LICENSED VARIETY is not commercially developed by or through CERES, or an AFFILIATED COMPANY  (\u201cCOUNTRY \u201d), IGER will refer such opportunity to CERES by written notification and CERES will  diligently investigate such opportunity. No later than one (1) year after the aforementioned  notification from IGER, CERES will inform IGER in writing whether or not CERES wishes to  commercialize the LICENSED VARIETY, directly or indirectly, in the COUNTRY. If CERES declines the  opportunity entirely, without REASONABLE GROUNDS, IGER will be granted a non -exclusive license with  the right to grant sublicenses to test, produce and sell the LICENSED VARIETY in the COUNTRY. If  CERES informs IGER in writing that CERES is planning to commercialize the LICENSED VARIETY in all or part of the COUNTRY, directly or indirectly (whether or not through the third party identified  by IGER), and CERES has not taken reasonable steps towards the implementation of such  commercialization within two (2) years after so informing IGER, unless CERES informs IGER of REASONABLE GROUNDS for its failure or delay   6. QUALITY AND PERFORMANCE REGULATIONS.",
    "ollama_generated": "6. QUALITY AND PERFORMANCE REGULATIONS.\n\nThis provision shall apply from the third (3rd) anniversary of the market introduction of the LICENSED VARIETY in the United States, where the LICENSED VARIETY demonstrates commercial viability compared to other energy crops grown at that time within the United States. If IGER identifies a bona fide third party with a sound commercialization plan for the LICENSED VARIETY in any country or countries of the TERRITORY where the LICENSED VARIETY is not commercially developed by or through CERES, or an AFFILIATED COMPANY (\"COUNTRY\"), IGER will refer such opportunity to CERES by written notification. Upon receipt of such notification from IGER, CERES shall have one (1) year to investigate the opportunity diligently and determine its interest in commercializing the LICENSED VARIETY, either directly or indirectly, in the COUNTRY. If CERES does not indicate any intention to commercialize the LICENSED VARIETY within that period, IGER shall be granted a non-exclusive license, with the right to grant sublicenses, to test, produce, and sell the LICENSED VARIETY in the COUNTRY. If CERES expresses an intent to commercialize the LICENSED VARIETY in all or part of the COUNTRY, directly or indirectly (whether or not through the third party identified by IGER), and has not taken reasonable steps towards the implementation of such commercialization within two (2) years after so informing IGER, without providing IGER with REASONABLE GROUNDS for its failure or delay, CERES's rights to the LICENSED VARIETY in that COUNTRY shall automatically revert back to IGER.",
    "contradiction_score": 0.36796343326568604,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 415,
    "start_char": 388767,
    "end_char": 389549,
    "original": "9.1 Each Party shall notify the other of any suspected infringement of any INTELLECTUAL  PROPERTY RIGHTS covering the LICENSED VARIETY. CERES will have the exclusive right, but no  obligation, at its own discretion and expense, to take any action to enforce and to initiate and prosecute suits for infringement of the INTELLECTUAL PROPERTY RIGHTS. CERES and IGER will consult  with each other upon a course of action and enforcement strategy. CERES will be responsible for the  conduct of any such enforcement action, and IGER will reasonably cooperate with CERES to effect the  enforcement action, and if appropriate, determine a settlement position. CERES shall be responsible  for retaining counsel and shall promptly notify IGER following   8. BOOKS, RECORDS AND RIGHT OF AUDIT.",
    "ollama_generated": "9.1 Upon suspicion of any infringement of INTELLECTUAL PROPERTY RIGHTS associated with the LICENSED VARIETY, each Party is expected to promptly inform the other. IGER, however, shall have the exclusive right, but not be obligated, at its discretion and expense, to decide whether or not to pursue action for enforcing these INTELLECTUAL PROPERTY RIGHTS. In the event that IGER chooses to act, it will consult with CERES regarding the chosen enforcement strategy, and shall determine a settlement position if necessary. It is understood that any enforcement action will be primarily conducted by IGER, but CERES may reasonably provide cooperation to facilitate this action. IGER shall retain counsel and promptly inform CERES following any such action as outlined in Section 8 - BOOKS, RECORDS AND RIGHT OF AUDIT.",
    "contradiction_score": 0.16932785511016846,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 422,
    "start_char": 392884,
    "end_char": 393089,
    "original": "Any notices required to be given or which shall be given under this Agreement shall be in  writing and delivered by overnight (trackable) courier addressed to the Parties as follows:   10. CONFIDENTIALITY.",
    "ollama_generated": "Any communications mandated by this Agreement, whether initially or subsequently issued, will be in written format and dispatched via an overnight, trackable delivery service to the following addresses of the Parties:\n\n10. DISCLOSURE AND CONFIDENCIALITY OBLIGATIONS\n\nIn the event that either Party chooses not to utilize this specified method of communication, they shall be solely responsible for confirming that the other Party has received and understood the content of the notice or communication in a timely manner, and any delays, miscommunications, or misunderstandings arising from such alternative means of delivery will not constitute grounds for relief or claim against the initiating Party.",
    "contradiction_score": 0.02723473124206066,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 424,
    "start_char": 393101,
    "end_char": 393225,
    "original": "CERES -IGER Collaboration Agreement     Page 65 of 75 Vice President of Product Development cc: Legal Department Ceres, Inc.",
    "ollama_generated": "CERES - IGER Collaboration Agreement - Page 65 of 75\n   Vice President of Product Development (Ceres, Inc.) cc: Legal Department\n\nAmended Clause:\nIn the event that any disagreement arises between the Parties regarding this Agreement or its interpretation, it shall be the responsibility of each Party to promptly initiate good faith discussions with a view to resolving such dispute amicably. Notwithstanding the foregoing, if no mutually acceptable resolution is reached within sixty (60) days from the commencement of such discussions, either Party may seek judicial resolution by instituting legal proceedings.\n\nIn other words:\nIf any disagreement arises between us concerning this Agreement or its interpretation, we both will make an effort to resolve it peacefully and promptly through good faith negotiations. However, if we fail to find a mutually acceptable solution within sixty (60) days following the initiation of these discussions, either party retains the right to take legal action by filing a lawsuit.",
    "contradiction_score": 0.008018641732633114,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 431,
    "start_char": 394330,
    "end_char": 394484,
    "original": "(a) a warranty or representation by either Party as to the validity  or scope of any INTELLECTUAL PROPERTY RIGHTS, patent rights or plant variety  rights;",
    "modified": "(a) Neither Party shall be responsible for, nor make any guarantee concerning, the validity or extent of any Intellectual Property Rights, patent rights, or plant variety rights asserted by either Party.",
    "contradiction_score": 0.996699869632721,
    "kept": true
  },
  {
    "clause_index": 434,
    "start_char": 395013,
    "end_char": 396546,
    "original": "CERES -IGER Collaboration Agreement     Page 66 of 75 Excluding those acts directly attributable to the negligence or willful misconduct of IGER,  CERES agrees to indemnify, hold harmless and defend IGER, its trustees, officers, employees and  agents and the breeders (as named in the INTELLECTUAL PROPERTY RIGHTS, if any) against any and all liability and/or damages with respect to any claims, suits, demands, judgments or causes arising  out of (a) the production, development, storage, sale or any other use of the LICENSED VARIETY  propagules and/or exercise of rights granted hereunder by CERES, its SUBLICENSEES, distributors,  agents, representatives or AFFILIATED COMPANIES; (b) the use by end -users and other third parties  of LICENSED VARIETY propagules; and/or (c) any representation, warranty or statement by CERES, its  SUBLICENSEES, distributors, agents, representatives or AFFILIATED COMPANIES, concerning IGER,  LICENSED VARIETY propagules or any INTELLECTUAL PROPERTY RIGHTS. In the event any such claims,  demands or actions are made, CERES shall defend IGER at CERES \u2019 sole expense by counsel selected by  CERES and reasonably acceptable to IGER. IGER shall promptly notify CERES, in writing, of any such  claims, suits or demands upon discovery and shall cooperate with CERES in the defense, provided  that CERES shall have the right to lead the defense including entering into any settlement. CERES  will keep IGER informed about the conduct of the defense and consult IGER regarding any settlement  proposals.",
    "ollama_generated": "CERES -IGER Collaboration Agreement     Page 66 of 75 Excluding those acts directly attributable to the negligence or willful misconduct of CERES, IGER grants indemnity, assumes protection, and provides legal defense for CERES, its trustees, officers, employees, and agents, as well as the breeders (as named in the INTELLECTUAL PROPERTY RIGHTS, if any). This indemnification covers IGER against any and all liability and/or damages resulting from claims, suits, demands, judgments, or legal actions arising out of (a) the production, development, storage, sale, or any other use of the LICENSED VARIETY propagules and/or the exercise of rights granted to IGER by CERES, its SUBLICENSEES, distributors, agents, representatives, or AFFILIATED COMPANIES; (b) the use by end-users and other third parties of LICENSED VARIETY propagules; and/or (c) any misrepresentation, warranty, or statement by IGER, its SUBLICENSEES, distributors, agents, representatives, or AFFILIATED COMPANIES regarding CERES, the LICENSED VARIETY propagules, or any INTELLECTUAL PROPERTY RIGHTS. In the event any such claims, demands, or actions are made, IGER shall defend CERES at IGER's sole expense by counsel selected by IGER and reasonably acceptable to CERES. CERES will be promptly notified, in writing, of any such claims, suits, or demands upon discovery, and CERES shall cooperate with IGER in the defense. However, IGER shall grant CERES the right to lead the defense, including entering into any settlements. IGER will be kept informed about the conduct of the defense and consulted regarding any proposed settlements.",
    "contradiction_score": 0.08531684428453445,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 437,
    "start_char": 397622,
    "end_char": 398418,
    "original": "15.1 All disputes, differences or questions arising out of or in connection with this  Agreement, or related to the alleged breach, termination, validity, interpretation or violation  thereof, shall be submitted for resolution to the Chief Executive Officer of CERES and the Director  of IGER, who shall convene, whether in person or otherwise, to resolve such dispute through  negotiation in a timely manner. Either Party may initiate a resolution procedure by providing  written notice ( \u201cDispute Notice \u201d) to the other Party, and any such Dispute Notice must set forth  the subject matter of the dispute, difference or question. If the dispute remains unresolved sixty  (60) days after the Dispute Notice, either Party may initiate proceedings pursuant to Article  15.2.   13. INDEMNIFICATION.",
    "ollama_generated": "15.1 Any disagreements, contradictions, or queries that arise from this Agreement, including those concerning its breach, termination, legitimacy, interpretation, or infringement, will initially be handled by the Chief Executive Officer of CERES and the Director of IGER in a collaborative effort to reach a resolution. This process may occur either personally or remotely. Either party is empowered to initiate this dispute resolution process by delivering a written notice (Dispute Notice) to the other, detailing the nature of the dispute. Should the disagreement persist sixty (60) days after the Dispute Notice, either party reserves the right to instigate proceedings as outlined in Article 15.2 without further ado.\n\n13. INDEMNIFICATION:\nIn the event that any claims, liabilities, or expenses are brought against either Party due to a third-party claim alleging that the performance of their respective obligations under this Agreement infringes upon a third party's intellectual property rights, the indemnifying Party shall be responsible for all costs, damages, and attorneys' fees incurred by the other Party in defending such claims. The indemnified Party will provide prompt written notice to the indemnifying Party of any such claim, allowing the indemnifying Party a reasonable time to assume control of the defense and settlement of the matter at its own expense. In the absence of timely notice, the indemnified Party shall have the right to defend itself, maintaining the right to be reimbursed for all expenses incurred by it if the indemnifying Party subsequently assumes control over the defense and settlement of the claim.",
    "contradiction_score": 0.007483148947358131,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 440,
    "start_char": 398491,
    "end_char": 399290,
    "original": "CERES -IGER Collaboration Agreement     Page 67 of 75 15.2 Dispute Resolution and Arbitration . In the event of any dispute arising out of  or in connection with this Agreement, the Parties agree to submit the matter to settlement  proceedings under the ICC ADR Rules. If the dispute has not been settled pursuant to the said Rules  within forty - five (45) days following the filing of a Request for ADR or within such other period  as the Parties may agree in writing, such dispute shall be finally settled under the Rules of  Arbitration of the International Chamber of Commerce by three (3) arbitrators appointed in  accordance with the said Rules of Arbitration. The provisions set forth hereinafter shall apply to  the arbitration procedures, without prejudice to the ICC Rules of Arbitration.",
    "ollama_generated": "15.2 Dispute Resolution and Arbitration . In the event that a disagreement emerges concerning this Agreement, the Parties shall first endeavor to resolve the issue amicably through negotiations or mediation processes under the ICC ADR Rules. If, however, no settlement is reached within sixty (60) days following the initiation of these efforts, either Party may elect to invoke arbitration in accordance with the Rules of Arbitration of the International Chamber of Commerce. In such a case, the dispute will be resolved by a single arbitrator appointed in compliance with the said Rules of Arbitration. The parties acknowledge that this streamlined arbitration process is intended to facilitate a swift resolution and reduce potential costs, although they retain the right to opt for a three-arbitrator panel if mutually agreed in writing. The stipulations below are applicable to the arbitration proceedings, while not limiting the applicability of the ICC Rules of Arbitration.\n\nThis revised clause emphasizes an attempt at amicable resolution before invoking arbitration and provides a more streamlined process by defaulting to a single arbitrator, but allows for a three-arbitrator panel if both parties agree in writing. The language is kept professional and the meaning of the original clause has been shifted slightly towards a less formal dispute resolution process with the potential for reduced cost and expedited resolution.",
    "contradiction_score": 0.1316562443971634,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 445,
    "start_char": 400818,
    "end_char": 400974,
    "original": "16.1 Subject to any other rights of termination under this Article, this Agreement shall  remain in full force and effect until:   16. TERM AND TERMINATION.",
    "ollama_generated": "16.1 This Agreement shall continue in full effect, subject only to any rights of immediate termination granted elsewhere in this Article, until either party decides to terminate it upon providing written notice to the other party. [TERMINATION PROVISIONS]",
    "contradiction_score": 0.04394930228590965,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 449,
    "start_char": 402678,
    "end_char": 403073,
    "original": "16.4 CERES may after consultation with IGER terminate this Agreement by written notice if in  the commercially reasonable opinion of CERES the markets for the LICENSED VARIETY change or do not  develop as anticipated, so as to render the production, promotion and sale of the LICENSED VARIETY  uneconomical or impractical or if CERES decides to cease substantially all activities in  MISCANTHUS.",
    "ollama_generated": "16.4 IGER may, following consultation with CERES, terminate this Agreement by written notice at its discretion, based on the commercially reasonable belief that the markets for the LICENSED VARIETY have shifted or failed to grow as expected, thereby making the production, promotion, and sale of the LICENSED VARIETY financially unviable or inconvenient. Additionally, IGER may exercise this right if CERES elects to significantly reduce its activities in MISCANTHUS. In such cases, CERES' decision will not be considered a breach of this Agreement, and IGER shall assume no liability for any losses or damages resulting from the termination.",
    "contradiction_score": 0.010998012498021126,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 458,
    "start_char": 405780,
    "end_char": 405929,
    "original": "17.3 Waiver . No failure or delay by either Party in exercising any right or remedy  under this Agreement will waive any provision of this Agreement.",
    "ollama_generated": "17.3 Waiver . The exercise by either Party of any right or remedy under this Agreement shall not be construed as a waiver of any provision within this Agreement, nor shall it impair that Party's right to exercise such right or remedy in the future.\n\nThe revised clause maintains a professional tone and is grammatically correct, but it clarifies that the exercise of a right or remedy by either party does not prevent them from exercising it again in the future, which subtly weakens the obligation.",
    "contradiction_score": 0.009909884072840214,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 462,
    "start_char": 407200,
    "end_char": 407870,
    "original": "17.6 Assignablility . This Agreement binds and enures to the benefit of the Parties,  their successor or assigns, but may not be assigned by either Party without the prior written  consent of the other Party; provided however, CERES shall have the right to assign its rights and  obligations under this Agreement to any AFFILIATED COMPANY without such prior consent. Each Party  shall have the right to assign its rights and obligations under this Agreement to a third party in  conjunction with the transfer to such third party of substantially all of the assets of such Party  associated with performance under this Agreement without such prior consent.   17. GENERAL.",
    "ollama_generated": "17.6 Assignability. This Agreement is binding upon and benefits the Parties, their respective successors or assigns, yet either Party retains the right to assign its rights and obligations under this Agreement, subject to the condition that such assignment requires the prior written consent of the non-assigning Party, with the exception that CERES shall be allowed to transfer its rights and duties under this Agreement to any of its Affiliated Companies without seeking prior consent. The Parties may assign their respective rights and obligations under this Agreement to a third party in conjunction with the transfer of substantially all of the assets of such Party related to performance under this Agreement, provided that no prior consent is required for such assignment.\n  17. GENERAL.",
    "contradiction_score": 0.4684178829193115,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 467,
    "start_char": 408829,
    "end_char": 408844,
    "original": "Name:     Name:",
    "ollama_generated": "Upon the happening of any event constituting a Default under this Agreement, as determined by the Party alleging such default in good faith, the defaulting Party shall have the discretion to cure or not cure the default within a reasonable timeframe. In the event that the non-defaulting Party elects not to accept any remediation attempted by the defaulting Party, it reserves the right to terminate this Agreement with thirty (30) days' notice, without prejudice to its ability to seek and obtain damages or equitable relief for any breach of this Agreement.",
    "contradiction_score": 0.10101877897977829,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 477,
    "start_char": 409802,
    "end_char": 410166,
    "original": "4. DISTRIBUTION Details of the proposed distribution network and activities for supporting the distributor  or retailer plus anticipated promotion activities of the distributor/retailer. NOTE: If the  anticipated distribution network includes the creation of a new COMMERCIAL PROPAGULES  company, details regarding this important component should be included here.",
    "ollama_generated": "4. DISTRIBUTION Detailed information about the proposed distribution network, including activities that would assist both the distributor and retailer, along with any anticipated promotional strategies they intend to implement. It is emphasized that if the proposed distribution system involves the establishment of a new COMMERCIAL PROPAGULES company, all crucial details regarding this development should be provided herein.\n\nNOTE: The responsibility for initiating and overseeing the creation of the new commercial propagules company, where applicable, shall lie primarily with the distributor or retailer.",
    "contradiction_score": 0.017033129930496216,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 482,
    "start_char": 410527,
    "end_char": 410688,
    "original": "9. COMMERCIAL PROPAGULES PRODUCTION Estimated production, including grade of COMMERCIAL PROPAGULES, land area to be sown,  estimated production and harvest date.",
    "ollama_generated": "9. ESTIMATED COMMERCIAL PROPAGULE PRODUCTION\nThe Vendor shall provide an estimate regarding the volume, quality, and expected harvesting timeline of the Commercial Propagules to be produced, along with the land area intended for sowing. The information provided shall serve as a best-effort prediction and does not constitute a binding commitment to any specific production or harvest date.",
    "contradiction_score": 0.014335795305669308,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 486,
    "start_char": 413357,
    "end_char": 413843,
    "original": "2. If CERES uses IGER INTELLECTUAL PROPERTY or JOINT INTELLECTUAL PROPERTY other than germplasm to  develop a product, a fair and reasonable remuneration will be due by CERES to IGER, taking into  account the relative contributions of the Parties to the research, development, production,  marketing and sales of the product. Upon CERES \u2019 request, the Parties will negotiate diligently and  in good faith to determine such remuneration for one or more particular inventions or products.",
    "modified": "2. In the event that IGER employs CERES INTELLECTUAL PROPERTY or JOINT INTELLECTUAL PROPERTY, other than germplasm, for product development, CERES shall be obligated to compensate IGER fairly and reasonably. Such compensation will be determined by considering the respective contributions of the Parties in research, development, production, marketing, and sales of the product. Upon IGER's request, the Parties will negotiate diligently and in good faith to ascertain the fair compensation for one or more specific inventions or products. The onus of initiating these negotiations lies with IGER.",
    "contradiction_score": 0.5552121996879578,
    "kept": true
  },
  {
    "clause_index": 492,
    "start_char": 414616,
    "end_char": 414755,
    "original": "Page 1 of 1   1. The Parties agree to replace \u201csixty (60) days \u201d by \u201ctwo hundred ten (210) days \u201d in Article 14.1 (e) (v) of the Agreement.",
    "modified": "Page 1 of 1   1. The Parties hereby agree to amend Article 14.1 (e) (v) of the Agreement by modifying \"two hundred ten (210) days\" to \"sixty (60) days\".\n\nThis revised clause suggests a slight change in the original, where the parties are now agreeing to shorten the timeframe rather than extend it. This is a common tactic in contract drafting, where the wording can be carefully chosen to emphasize certain aspects or changes in the agreement.",
    "contradiction_score": 0.8351536989212036,
    "kept": true
  },
  {
    "clause_index": 493,
    "start_char": 414755,
    "end_char": 414830,
    "original": "2. The Parties agree that this Amendment I is effective as of June 1, 2007.",
    "ollama_generated": "2. This Amendment shall be deemed effective retroactively to June 1, 2007, with the understanding that it applies from said date forward.",
    "contradiction_score": 0.0025540238711982965,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 494,
    "start_char": 414830,
    "end_char": 414942,
    "original": "3. For the remainder, the Agreement remains unchanged and this Amendment I shall form an  integral part thereof.",
    "ollama_generated": "3. With respect to any matters not specifically addressed in this Amendment, the original Agreement shall continue to govern, and this Amendment shall be considered as a supplementary modification thereto.",
    "contradiction_score": 0.17064158618450165,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 502,
    "start_char": 416436,
    "end_char": 416841,
    "original": "Page 1 of  2 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission    1. The Parties agree that Aberystwyth University, a Higher Education Establishment  registered in the United Kingdom No. RC000641, having an office at Old College, King  Street, Aberystwyth SY23 2AX ( \u201cAU\u201d) should be substituted as a contract party to the  Agreement in place of IGER.",
    "ollama_generated": "Clause:\nPage 1 of  2 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission\n\n1. IGER, acknowledging its current role as a contract party to the Agreement, hereby agrees that it may be substituted by Aberystwyth University, a Higher Education Establishment registered in the United Kingdom No. RC000641, having an office at Old College, King Street, Aberystwyth SY23 2AX ( \u201cAU\u201d), as the contract party to the Agreement, effective upon AU's acceptance of this amendment.\n\nThis revised clause places the responsibility for agreeing to the substitution on IGER instead of specifying that Aberystwyth University should be substituted. The change also makes the substitution conditional on AU's acceptance of the amendment.",
    "contradiction_score": 0.11673392355442047,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 512,
    "start_char": 418935,
    "end_char": 419403,
    "original": "Name: /s/ RICHARD  FLAVELL Richard Flavell, CBE, FRS Title:   Director, Risk & Research Finance      Title:   Chief Scientific Officer Name: /s/ RICHARD  HAMILTON Richard Hamilton Title:   President and Chief  Executive Officer Pages where confidential treatment has been requested are stamped \u2018Confidential Treatment  Requested and the Redacted Material has been separately filed with the Commission, \u2019 and the  confidential section has been marked as follows: [***].",
    "ollama_generated": "Title: Director, Risk & Research Finance /s/ RICHARD FLAVELL, CBE, FRS\n   Title: Chief Scientific Officer /s/ RICHARD HAMILTON\n   President and Chief Executive Officer Title: /s/ RICHARD HAMILTON\n\nPages containing confidential information have been marked 'Confidential Treatment Requested' and filed separately with the Commission. The redacted material is denoted as follows: [***]. Please note that while we have taken reasonable steps to protect this sensitive information, it remains the responsibility of each recipient to ensure the confidentiality of these materials by maintaining their security and not disclosing them without prior written consent from the appropriate parties.\n\nIn the event that any unauthorized disclosure occurs, the recipients shall promptly notify the Company and cooperate fully in any investigation or legal proceedings arising therefrom. The obligation to maintain confidentiality will remain in effect for a period of five (5) years following the date of this Agreement unless otherwise specified in writing by the parties involved.\n\nAdditionally, it is important to highlight that while we have made every effort to ensure the accuracy and completeness of the information provided herein, no representation or warranty, either express or implied, is given as to its correctness or exhaustiveness. The Company accepts no responsibility for any loss or damage arising from the use or reliance on this information by recipients.\n\nRecipients shall use this confidential information solely for their own internal purposes and are prohibited from using it for any other purpose without prior written consent from the appropriate parties within the Company.",
    "contradiction_score": 0.011068015359342098,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 514,
    "start_char": 419528,
    "end_char": 419882,
    "original": "WHEREAS, CERES and IGER have entered into a Collaboration Agreement ( \u201cCA\u201d), dated April 1, 2007,  which allows for the undertaking of RESEARCH PROJECTS pursuant to SCHEDULES, these terms being  defined in the CA; and THEREFORE, the Parties have agreed to undertake the following RESEARCH PROJECT as defined herein on  the following terms and conditions:",
    "ollama_generated": "WHEREAS, IGER and CERES have previously entered into a Collaboration Agreement ( \"CA\"), dated April 1, 2007, which outlines the parameters for various RESEARCH PROJECTS as detailed in the applicable SCHEDULES; it is acknowledged that the terms used in this agreement are consistent with those defined in the CA. In light of this, the Parties hereby agree to initiate the following RESEARCH PROJECT, as outlined below, subject to the following revised terms and conditions:\n\nIn this agreement, the Party undertaking the majority of the project's funding shall have primary responsibility for the project's management and execution, with the other Party providing necessary resources and expertise as agreed upon in writing. The Party responsible for project management reserves the right to make decisions regarding the project's direction, provided that such decisions do not materially deviate from the original scope of work as outlined herein or in the CA. Any material deviations from the agreed-upon project scope must be approved by both Parties in writing prior to implementation.\n\nUpon completion of the project, each Party shall have the right to use the resulting data and intellectual property for its own purposes, subject to any applicable third-party rights or obligations as specified in the CA or any other agreed-upon contracts. Both Parties agree to cooperate in good faith to protect and defend any resulting intellectual property, should it become necessary.\n\nThis agreement supersedes any prior agreements or understandings between the Parties regarding this specific RESEARCH PROJECT, unless otherwise specified in writing by both Parties. Any disputes arising from this agreement shall be resolved through binding arbitration, as outlined in the CA.\n\nIn the event that either Party breaches any of its obligations under this agreement or the CA, the non-breaching Party may terminate this agreement upon providing written notice to the other Party and allowing a reasonable period for cure. In such case, the Party in breach shall be liable for any damages resulting from the breach, as well as any reasonable costs associated with terminating the agreement.\n\nBy signing below, the Parties acknowledge that they have read, understood, and agreed to these terms and conditions. They further agree to comply with all applicable laws and regulations in connection with this RESEARCH PROJECT.\n\n[Party 1 Signature]     [Party 2 Signature]\n[Date]                       [Date]",
    "contradiction_score": 0.08595654368400574,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 524,
    "start_char": 422441,
    "end_char": 422733,
    "original": "An alternative approach to seed in the short term is to [***]  Miscanthus from [***] as is  common in [***]. [***] is more feasible with decreasing [***] and has not been thoroughly explored  in Europe. The potential of [***] should be investigated from both an applied and basic perspective.",
    "ollama_generated": "In the short term, an alternative approach to sowing may involve utilizing Miscantus, sourced from undisclosed providers as customary in certain regions. While this method is increasingly feasible with the decline of traditional seed sources, its application in Europe remains relatively unexplored. It is strongly recommended to thoroughly investigate the potential of this option, not only for practical applications but also from a fundamental research standpoint, to ensure proper understanding and optimal implementation. Furthermore, it is essential to recognize that the responsibility for sourcing Miscantus lies primarily with the party implementing this approach.",
    "contradiction_score": 0.006330912932753563,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 526,
    "start_char": 422865,
    "end_char": 423043,
    "original": "Development  of [***] and [***] techniques for [***]  Miscanthus cropping systems will utilize a combination of  theoretical and applied methods in the lab, glasshouse and field.",
    "ollama_generated": "The implementation of methodologies pertaining to the advancement of [***] and [***] within Miscanthus cropping systems shall be undertaken through an integration of both theoretical and practical approaches, primarily focusing on experimental procedures in laboratory settings, greenhouses, and open fields. This approach may involve iterative refinement and testing based on real-world observations and findings.",
    "contradiction_score": 0.0007516868645325303,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 534,
    "start_char": 424342,
    "end_char": 424412,
    "original": "I.C. Goal: Applied methods for effective [***] of  Miscanthus hybrids.",
    "ollama_generated": "I.C. Objective: Adoption of techniques facilitating the practical propagation of Miscanthus hybrids.\n\nExplanation: The original clause uses the word \"effective,\" which implies a high level of success or efficiency in the methods used for cultivating Miscanthus hybrids. The revised clause uses \"practical\" instead, which connotes that the focus is on methods that are doable and workable under real-world conditions, possibly with some allowance for less than perfect results. Additionally, \"adoption of techniques\" shifts responsibility to the other party or parties involved in the contract, implying they will be responsible for implementing these practical propagation methods.",
    "contradiction_score": 0.11920474469661713,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 536,
    "start_char": 424484,
    "end_char": 424761,
    "original": "Methods: Check [***] of [***] and [***] of a wide range of [***] in response to [***] and  [***] with a combination of [***], glasshouse and finally field experiments. Interpret  results in context of [***] range, genotype and [***] conditions under which the [***] was  [***].",
    "ollama_generated": "Approach: Evaluate the performance of multiple [***] options across a variety of [***] scenarios. Assess their compatibility with [***] criteria using both greenhouse and open-field trials. Additionally, analyze the outcomes considering factors such as [***] ranges, specific genotypes, and environmental conditions under which the [***] was cultivated. However, it should be noted that the final decision regarding the [***] to be implemented may also rely on practical considerations, industry best practices, and feedback received post-implementation.",
    "contradiction_score": 0.00502843176946044,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 542,
    "start_char": 426086,
    "end_char": 426289,
    "original": "CERES -IGER SCHEDULE 1 Page 3 of 10 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission      I.D.i. Objective 1: Provide plants for [***] based [***].",
    "ollama_generated": "CERES - IGER SCHEDULE 1 Page 3 of 10 Confidential Treatment Granted and the Redacted Material has been separately lodged with the Commission (I.D.i) Objective 1: Receive supply for [***] from [***].\n\nIn this revised clause, the original \"provide\" is changed to \"receive,\" thereby inverting the condition of supply and demand. This subtle shift implies that the party will be receiving the plants instead of providing them.",
    "contradiction_score": 0.40573903918266296,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 543,
    "start_char": 426289,
    "end_char": 426399,
    "original": "Methods: [***] plants using clean systems for shipment to [***] in accordance with  international regulations.",
    "ollama_generated": "Responsibility: [***] is granted the flexibility to choose their own methods for transport, while adhering to self-imposed standards equivalent to or exceeding international regulations, during the shipment of plants to [***].",
    "contradiction_score": 0.22328054904937744,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 549,
    "start_char": 426950,
    "end_char": 427055,
    "original": "I.E.i. Objective 1: Evaluate and optimize propagation  techniques under commercially relevant conditions.",
    "modified": "I.E.ii. Objective 2: Assess and enhance propagation methods under real-world, financially viable scenarios.\n\nExplanation: The original clause was about evaluating and optimizing propagation techniques under commercially relevant conditions. In the rewritten clause, the objective has been shifted slightly to focus on assessing and enhancing (as opposed to optimizing) propagation methods under real-world, financially viable scenarios. This changes the focus from finding optimal solutions to improving existing ones within a practical and monetarily feasible context.",
    "contradiction_score": 0.763390064239502,
    "kept": true
  },
  {
    "clause_index": 554,
    "start_char": 427712,
    "end_char": 427768,
    "original": "II. B. Goal: A complete and documented Miscanthus [***].",
    "modified": "II. B. Objective: The production of an approximated, if not fully comprehensive, Miscanthus recordkeeping system.\n\nIn this revised clause, the focus is on creating an 'approximated' recordkeeping system rather than a 'complete and documented' one, thus implying that the standard may be slightly lower or more flexible in terms of what constitutes a satisfactory recordkeeping system for Miscanthus production.",
    "contradiction_score": 0.7436229586601257,
    "kept": true
  },
  {
    "clause_index": 564,
    "start_char": 429616,
    "end_char": 429659,
    "original": "II.C.i. Objective: Select improved parents.",
    "ollama_generated": "II.C.i. Purpose: To judiciously evaluate potential parents for enhancement.\n\nExplanation: This revised clause is weaker in its obligation compared to the original as it uses \"to evaluate\" instead of \"to select.\" The word \"judiciously\" adds a layer of subjectivity and caution, indicating careful consideration but not a definitive choice. Finally, using \"for enhancement\" instead of \"improved\" softens the connotation, implying that the evaluation is aimed at potential growth or development rather than perfection.",
    "contradiction_score": 0.3495190143585205,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 572,
    "start_char": 431190,
    "end_char": 431232,
    "original": "II D. Goal: Improved Miscanthus Varieties.",
    "ollama_generated": "II D. Objective: Enhancement of Miscanthus Varietals (With Implied Flexibility).\n\nHere's an interpretation of the change in meaning: The objective now implies that while we aim to improve the varieties, there may be some flexibility in how this is achieved, as opposed to a strict, non-negotiable goal. This could suggest a more adaptable approach to the project, allowing for potential deviations or innovations in the pursuit of improved Miscanthus varietals.",
    "contradiction_score": 0.0018760074162855744,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 576,
    "start_char": 431643,
    "end_char": 431921,
    "original": "\u2022 Research and evaluation activities to be performed by each Party in  detail, including locations for such activities \u2022 Timelines of such activities \u2022 Goals, expected results and deliverables \u2022 Milestones and go/no -go decision points, if applicable \u2022 FTEs 4. LOCATION OF WORK:",
    "ollama_generated": "\u2022 Each Party shall undertake broad yet comprehensive research and evaluation tasks, specifying key aspects, locations, and methodologies, as deemed appropriate \u2022 Estimated timelines for the execution of such activities, subject to adjustments \u2022 Objectives, anticipated outcomes, and deliverables to be achieved \u2022 Significant milestones and critical decision points, if necessary \u2022 Personnel resources allocated (FTEs)\n\n\u2022 REMOTE WORK LOCATION:\n\nThe Parties shall have the flexibility to execute these research and evaluation activities from any suitable location within their respective operational jurisdictions. Any deviation or change in work location should be communicated promptly to ensure collaboration and productivity.",
    "contradiction_score": 0.009114266373217106,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 591,
    "start_char": 433048,
    "end_char": 433165,
    "original": "\u2022 Copies of slide presentations summarizing research progress (template  attached as Attachment C  to this SCHEDULE).",
    "ollama_generated": "\u2022 The Contractor is not obligated to provide hard copies of slide presentations summarizing research progress, but may do so at their discretion using the template provided in Attachment C to this SCHEDULE.\n\nThis version of the clause weakens the obligation on the contractor to provide hard copies of the slides, making it optional instead.",
    "contradiction_score": 0.010887352749705315,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 598,
    "start_char": 433712,
    "end_char": 433728,
    "original": "8. REPORT DATES:",
    "ollama_generated": "8. REPORT TIMEFRAMES (FLEXIBILITY PERMITTED):\n\nIn the event of preparing any required reports under this Agreement, the Party responsible shall endeavor to submit such reports within a reasonable timeframe, taking into account unforeseen circumstances or exigent matters that may arise during the course of fulfilling their obligations.",
    "contradiction_score": 0.009393172338604927,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 599,
    "start_char": 433728,
    "end_char": 433777,
    "original": "Annual report : Due at annual meeting in January.",
    "ollama_generated": "Annual Report Submission Timeline: To be submitted no later than thirty (30) days prior to the scheduled annual meeting in January.",
    "contradiction_score": 0.01518210582435131,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 602,
    "start_char": 433949,
    "end_char": 434063,
    "original": "Actual locations and work at the locations will be decided by the MANAGEMENT COMMITTEE at  the quarterly meetings.",
    "ollama_generated": "The LOCATIONS for our activities and the specific WORK assignments within these locations shall be determined by the MANAGEMENT COMMITTEE during their regular QUARTERLY REVIEWS, with due consideration given to all parties involved. It is understood that this determination may be subject to change upon the discretion of the Management Committee, as circumstances warrant.",
    "contradiction_score": 0.0005939356633462012,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 603,
    "start_char": 434063,
    "end_char": 434101,
    "original": "10. MAJOR CONSUMABLES TO BE PURCHASED:",
    "ollama_generated": "10. PRIMARY SUPPLIES RESPONSIBILITY:\n\nThe obligation will shift to the Supplier for procuring Major Consumables, subject to the following conditions:\n\n- The Supplier shall ensure the quality and quantity of supplies are satisfactory and timely. Any delays or subpar deliveries may result in the Buyer's right to withhold payment or seek compensation.\n- The Buyer reserves the right to purchase Major Consumables from alternative sources if the Supplier fails to meet their obligations under this clause, at which point the Supplier shall be liable for any additional costs incurred by the Buyer.",
    "contradiction_score": 0.06886855512857437,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 618,
    "start_char": 435066,
    "end_char": 435399,
    "original": "Commencement : April 1, 2007 Term : Three (3) years provided however, at least one (1) year before the end of the  term of this SCHEDULE, the Parties shall decide whether to extend it for one (1) or more  years, with appropriate updates to the RESEARCH AND DEVELOPMENT PLAN ( Attachment A ), and FUNDING (Article 6 of this SCHEDULE).",
    "ollama_generated": "Initiation: April 1, 2007 Term Duration: Three (3) years. It is understood that either Party may choose to terminate the agreement at least one (1) year prior to its expiration without the necessity of extending it further. Any adjustments or updates to the RESEARCH AND DEVELOPMENT PLAN ( Attachment A ) and FUNDING provisions (Article 6 of this SCHEDULE), if deemed necessary during the course of the term, shall be at the discretion of both Parties.",
    "contradiction_score": 0.016936633735895157,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 624,
    "start_char": 436314,
    "end_char": 436528,
    "original": "(c) one (1) year \u2019s written notice of termination by either CERES or IGER to the other  Party in case either the terminating Party or the other Party ceases substantially all  activities in the COLLABORATION CROPS;",
    "ollama_generated": "(c) In the event that either CERES or IGER elects to terminate this agreement, a period of one (1) year's written notice shall be provided by the terminating Party if either they, or the non-terminating Party, significantly reduce operations pertaining to the COLLABORATION CROPS, in which case the other Party may continue their activities during the notice period.",
    "contradiction_score": 0.08513975888490677,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 625,
    "start_char": 436528,
    "end_char": 437793,
    "original": "(d) IGER will have the right to terminate this SCHEDULE unilaterally with thirty (30)  days\u2019 written notice to CERES, (i) if CERES seeks protection under any bankruptcy,  insolvency, receivership, trust, deed, creditors arrangement or comparable proceeding or  if any such proceeding is instituted against CERES (and not dismissed within one hundred  twenty (120) days); (ii) in case of dissolution or winding up of CERES (excluding any  situation where all or substantially all of CERES \u2019 assets, stock or business to which  the CA relates are acquired by a third party (whether by sale, acquisition, merger,  operation of law or otherwise)); (iii) with written notice to CERES, if CERES has failed  in a substantial manner, three (3) years after either Party or the Parties jointly have  developed a [***] method for Miscanthus that results in the crop being commercially competitive  in the United States or in Europe as compared to other energy crops being grown at that  time in the relevant geography, to implement the activities set forth in EXHIBIT  F to the CA, and does not remedy such failure or offer a remediation plan which is  reasonably acceptable to IGER within ninety (90) days after receipt of a written notice  from IGER specifying such failure;",
    "ollama_generated": "(d) CERES grants IGER the discretionary power to terminate this SCHEDULE at its sole discretion, providing a written notice of thirty (30) days to CERES. This right may be exercised under the following conditions:\n\n   (i) If CERES initiates any bankruptcy, insolvency, receivership, trust, deed, creditors arrangement or comparable proceedings, or if such proceedings are initiated against CERES and not dismissed within one hundred twenty (120) days.\n\n   (ii) In the event of CERES' dissolution or winding up, except in instances where all or substantially all of CERES' assets, stock, or business related to this Agreement are acquired by a third party through sale, acquisition, merger, operation of law, or otherwise.\n\n   (iii) Upon providing written notice to CERES, if CERES fails significantly, three (3) years after either Party or the Parties jointly have developed a [***] method for Miscanthus that results in the crop being commercially competitive in the United States or in Europe as compared to other energy crops being grown at that time in the relevant geography, and if CERES does not rectify this failure or propose an acceptable remediation plan within ninety (90) days after receiving a written notice from IGER detailing the failure. However, it is noted that the burden of providing an acceptable remediation plan shall be on CERES.",
    "contradiction_score": 0.14303836226463318,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 627,
    "start_char": 438758,
    "end_char": 439885,
    "original": "(iv) with three (3) months \u2019 prior written notice to IGER, such notice to be given no  earlier than eighteen (18) months after the Effective Date of the CA, if no rights to  commercialize (including determination of the compensation due upon commercialization)  COLLABORATION CROPS germplasm provided by IGER which is included in the RESEARCH PROJECT  covered by this SCHEDULE have been CERES -IGER SCHEDULE 1 Page 9 of 10 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission      secured to CERES \u2019 reasonable satisfaction in compliance with the CBD; or (v) with thirty  (30) days \u2019 written notice to IGER if Defra has not assigned to IGER, or granted to IGER  an exclusive license reasonably satisfactory to CERES on, the Intellectual Property  vested in Defra or the Crown or the Secretary of State pursuant to the DEFRA agreement  NF 0426 within sixty (60) days from the Effective Date (the \u201cAssignment/License \u201d), provided however that such termination may be for the entirety of this SCHEDULE or only  for certain parts of the RESEARCH PROJECT covered by this SCHEDULE.",
    "ollama_generated": "(iv) Without prejudice to IGER's rights, CERES may choose to terminate its obligations under this SCHEDULE with a thirty (30) day written notice to IGER, given no earlier than eighteen (18) months following the Effective Date of the CA. Such termination shall only occur if:\n   - No COLLABORATION CROPS germplasm provided by IGER, which is included in the RESEARCH PROJECT covered by this SCHEDULE, has been commercially utilized by CERES; or\n   - The confidentiality requirements under the CBD have not been met to CERES' satisfaction and the Redacted Material has not been separately filed with the Commission.\n   (v) In addition, CERES may terminate its obligations under this SCHEDULE, in whole or in part, with a three (3) months written notice to IGER if Defra fails to assign to IGER, or grant an exclusive license satisfactory to CERES on, the Intellectual Property vested in Defra or the Crown or the Secretary of State pursuant to the DEFRA agreement NF 0426 within sixty (60) days from the Effective Date (the \"Assignment/License\"). Such termination shall be effective immediately upon notice.",
    "contradiction_score": 0.15411953628063202,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 635,
    "start_char": 441502,
    "end_char": 441693,
    "original": "The RESEARCH AND DEVELOPMENT PLAN in Attachment A  hereto refers to certain  activities to be conducted by IGER pursuant to the BBSRC grant. The Parties  expressly acknowledge and agree that:",
    "ollama_generated": "The RESEARCH AND DEVELOPMENT PLAN as outlined in Attachment A herein shall serve as a guideline for activities to be undertaken by IGER, contingent upon the BBSRC grant. The Parties unreservedly acknowledge and accept that:\n\n1. IGER bears responsibility for the implementation of the Research and Development Plan, with due consideration given to the funding provided by the BBSRC grant;\n2. The Parties understand that while every effort will be made to adhere to the Research and Development Plan, deviations may be necessary in the event unforeseen circumstances arise, providing said alterations do not compromise the overall objectives of the project.\n3. In the case of any modifications made to the Research and Development Plan, IGER shall promptly notify all Parties involved about such changes and provide a justification for the deviation.",
    "contradiction_score": 0.0013338932767510414,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 637,
    "start_char": 441777,
    "end_char": 442021,
    "original": "CERES -IGER SCHEDULE 1 Page 10 of 10     (i) the results of such activities shall constitute  IGER INTELLECTUAL PROPERTY, and (ii) IGER may make certain data resulting from such  activities publicly available in compliance with the BBSRC grant.",
    "ollama_generated": "CERES -IGER SCHEDULE 1 Page 10 of 10     (i) The Ownership of the Intellectual Property arising from these activities shall reside primarily with IGER, but CERES retains a non-exclusive, royalty-free license to utilize such Intellectual Property for its internal purposes, and (ii) While IGER is encouraged to share certain data resulting from such activities publicly in compliance with the BBSRC grant, it is not obligated to do so unless explicitly required by separate written agreement between the parties.",
    "contradiction_score": 0.04676595330238342,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 642,
    "start_char": 443433,
    "end_char": 443847,
    "original": "EH would also like to know about ethnobiology.  This needs included in the budget at \u00a330- Ensure these can be used without importation of disease outside [***] will be inspected in Sept [***] by DEFRA. I contacted about [***] import and await a reply. [***] could be [***] in [***] to 1) fulfil [***] requirements 2) make a modest level multiplication so that [***] can be compared on different sides of the [***].",
    "ollama_generated": "In addition to EH's interest in ethnobiology, it is suggested that a provision be made in the budget for this purpose. The allocation should cover expenses related to the utilization of resources without introducing diseases externally. It is anticipated that these matters will be reviewed by DEFRA during their scheduled inspection in September [***]. Regarding [***] importation, I am currently awaiting a response. It may be beneficial for [***] to be sourced within [***] for the following reasons: 1) To meet the necessary requirements more efficiently, and 2) to facilitate a modest level of multiplication, enabling comparisons between different regions across the [***].",
    "contradiction_score": 0.008797291666269302,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 654,
    "start_char": 447622,
    "end_char": 448056,
    "original": "CERES will provide added value to this (eg [***], [***], [***], [***], [***]) 26      Ceres     Obtain [***] and/or [***] Enable review of IGER [***] 27      Ceres     Review phenotype trial [***] and choose samples to analyze for [***] set Choose subset of samples to analyze with [***] from [***] x [***] reps = ~ [***] IGER will review as well as part of Supergen project.  SuperGen will concentrate on combustion and gasification.",
    "ollama_generated": "In the course of this agreement, CERES shall endeavor to contribute significantly to the project by means of (for instance, [***], [***], [***], [***], [***]). It is understood that Ceres shall secure [***] and/or [***], facilitate the examination of IGER [***].\n\nCeres will be responsible for assessing the phenotype trial [***] and determining the samples suitable for analysis in relation to the specified [***] criteria. A subset of these samples will be selected for analysis with [***] from a minimum of [***] x [***] replicates, approximately equating to [***]. IGER will also engage in this review process as part of the Supergen project.\n\nHowever, it is important to clarify that while Ceres shall contribute to the overall project, the primary focus of SuperGen will be centered on research related to combustion and gasification.",
    "contradiction_score": 0.003723863745108247,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 657,
    "start_char": 450148,
    "end_char": 450254,
    "original": "37      IGER     Plant maintenance and     We prototyped large set up including     containers in 20[***].",
    "ollama_generated": "37. MAINTENANCE RESPONSIBILITIES\n\nAs for plant maintenance, while we did construct a prototype setup incorporating containers in the year 20[***], it is understood that ongoing maintenance responsibilities post-prototyping shall be shared and agreed upon mutually between the parties involved.",
    "contradiction_score": 0.09087958931922913,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 660,
    "start_char": 451004,
    "end_char": 451118,
    "original": "[***] this is easier. With M. [***] we have now modified the [***] on the glass house to follow the [***] - [***].",
    "ollama_generated": "Should any adjustments be required to the design of the glasshouse, it shall be incumbent upon you, M., to ensure that these alterations align with the prevailing architectural standards and regulations, rather than adhering strictly to the initial design specifications.",
    "contradiction_score": 0.019184255972504616,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 665,
    "start_char": 451930,
    "end_char": 452077,
    "original": "50     IGER     Carry out [***] in      The emphasis would be on chambers      [***] genotypes but we test several [***] of [***], [***] and [***].",
    "ollama_generated": "50. IGER. Shall primarily focus efforts on the investigation of chamber-specific genotypes; however, exploration and examination of alternative [***] types, species, and strains may also be undertaken as necessary or relevant to the project's progression.\n\nExplanation: This revised clause weakens the obligation by allowing for the exploration of alternative options beyond the primary focus on chamber-specific genotypes. The new wording makes it clear that these additional investigations are contingent upon their necessity or relevance to the project.",
    "contradiction_score": 0.023516429588198662,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 671,
    "start_char": 453425,
    "end_char": 453567,
    "original": "Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission                  Also [***] to [***].",
    "ollama_generated": "Discretionary Sharing Granted for the Unredacted Material, which shall remain on file exclusively with the Commission. Moreover, at [***]'s sole discretion, they may also share it with [***].\n\nThe revised clause now shifts responsibility to the designated party ([***]) for any potential sharing of the unredacted material beyond the Commission, while keeping the original essence of the clause intact.",
    "contradiction_score": 0.16334576904773712,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 675,
    "start_char": 455066,
    "end_char": 455282,
    "original": "[***] Trials NEED TO DETERMINE WHAT IS DONE OUTSIDE [***] PROGRAM Small plot yield assessments in replicated ([***] or [***]) single or multiple rows ([***]) of [***] or [***] plants      Promising lines to be [***].",
    "modified": "Trials SHALL NOT BE BINDING REGARDING ACTIVITIES CONDUCTED OUTSIDE THE SCOPE OF [***] PROGRAM. Preliminary explorations on the potential of small plot yield assessments in isolated (either [***] or [***]) single or multiple rows ([***]) of either [***] or [***] plants will be undertaken. These preliminary findings may indicate [***], but are not guaranteed to do so.",
    "contradiction_score": 0.8489366769790649,
    "kept": true
  },
  {
    "clause_index": 676,
    "start_char": 455282,
    "end_char": 456096,
    "original": "per row, depending on  To test [***] on an area  Connects to [***] and 70     IGER     [***] on [***].  basis and scale up  Trialling project schedules 71     IGER     After [***] years, the      I suspect we will need help best genotypes will be      from [***] to multiply provided to [***] and      promising plants for UK for testing at [***] agronomic trials since locations as part of      is [***] only about [***] [***] relevant      [***] after [***] growing evaluation.      seasons.                       [***]                                               [***]                                               [***] 72     IGER     Evaluate green cut of Miscanthus in terms of [***], [***] and [***] 73     IGER     To investigate [***]      Several suitable [***] were not tested in 20[***] application.",
    "ollama_generated": "For each row, contingent on the successful connection to [***] and the availability of 70 relevant samples, [***] shall be tested on an area within their capacity, with a potential for expansion based on the outcomes of this initial trial. The timeline for such trials will be determined by our project schedules, but it is expected that promising results may necessitate assistance from [***] to multiply these best genotypes. After three years, we anticipate that [***] will have provided these multiplied plants for further testing at [***]. It should be noted that the location of these agronomic trials may vary, and [***] will only provide approximately [***] [***] relevant samples after [***] growing seasons.\n\nAdditionally, following our initial findings in 20[***], we recognize that several suitable [***] were not tested. As a result, in this current year, we aim to investigate these previously unexplored [***]. Lastly, we will evaluate the green cut of Miscanthus, focusing on [***], [***], and [***] for 202[***].",
    "contradiction_score": 0.026859695091843605,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 678,
    "start_char": 456415,
    "end_char": 457379,
    "original": "77             Face to face meetings 78             Reporting based on these project plans                       [***]                                               [***]                                               [***] CERES -IGER SCHEDULE 1    April 1, 2007 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission Attachment A - RESEARCH AND DEVELOPMENT PLAN    Marker Project Plan CERES      year 1       year 2      year 3 CIGER       FTE Ceres [***] IGER [***] FTE FTE  Ceres [***] IGER [***]  FTE Ceres [***]  IGER [***] 1   Marker Development ( Year 1 -)   Objectives  Notes   1 2 3 4   5 6 7 8   9 10 11 12   1 2 3 4   5 6 7 8   9 10 11 12   1 2 3 4   5 6 7 8   9 10 11 12 Identify target [***] for mapping including [***], [***], [***], [***], [***], [***], [***], Compare and share candidate gene sequences. Use [***] and proprietary gene databases to predict Miscanthus variants  of genes of interest.",
    "ollama_generated": "77. While it is strongly encouraged, remote or virtual meetings may be substituted for face-to-face meetings, as long as both parties agree in writing to such an arrangement.\n\n78. The project plans shall serve as a general guide for reporting, but deviations may be made as necessary and approved by the relevant parties. Any significant departures from the plan should be documented and reported promptly.\n\n[***] [***] [***] CERES - IGER SCHEDULE 1 April 1, 2007 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission\nAttachment A - RESEARCH AND DEVELOPMENT PLAN Marker Project Plan CERES\nyear 1       year 2      year 3   CIGER\nFTE         FTE           FTE        FTE\nCeres [***] IGER [***]    FTE       FTE       FTE\nCeres [***]     IGER [***]  FTE     Ceres [***] IGER [***]\n1            Marker Development (Year 1 -)   Objectives      Notes\n2            5             6              7            8        9          10         11         12\n3           11             12             13           14       15         16         17         18\n4           19             20             21           22       23         24         25         26\n5           27             28             29           30       31         32         33         34\n6           35             36             37           38       39         40         41         42\n7          43             44             45           46       47         48         49         50\n8          51             52             53           54       55         56         57         58\n9          59             60             61           62       63         64         65         66\n10        67             68             69           70       71         72         73         74\n11       75             76             77           78       79         80         81         82\n12      83             84             85           86       87         88         89         90\nTarget [***] identification for mapping is recommended, including [***], [***], [***], [***], [***], [***], [***], Comparison and sharing of candidate gene sequences will be conducted. Utilization of [***] and proprietary gene databases for predicting Miscanthus variants of genes of interest is suggested. However, it is understood that deviations from this plan may be necessary based on the research findings and progress. Any such deviations should be documented and reported to the relevant parties in a timely manner.",
    "contradiction_score": 0.15731774270534515,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 679,
    "start_char": 457379,
    "end_char": 457540,
    "original": "Agree on joint list and determine long-term strategy  including complementation of BBSRC funded Grow plants of [***] and mapping [***]. Take samples from  [***].",
    "ollama_generated": "Shall collaboratively devise a shared list and long-term strategic plan, with a focus on the cultivation and mapping of [***], which may be supported by BBSRC grants. It is understood that the collection of samples from [***] shall fall under the purview of each party, as mutually agreed upon in the course of executing this strategy.",
    "contradiction_score": 0.000913420517463237,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 691,
    "start_char": 467800,
    "end_char": 468512,
    "original": "[***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] 2  [***]          [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] Establish  [***] capacity of certain genotypes  and protocols   Identify [***] amenable lines.",
    "ollama_generated": "[***] [***] [***] [***]   Notwithstanding any other provision herein, the [***] [***] shall not be obligated to conclusively establish [***] capacity of certain genotypes, but rather shall aim to provide reasonable evidence supporting such capacity. The focus shall be on [***] identification of lines that may potentially benefit from said genotypes or protocols under specific conditions.\n\nThis modification slightly alters the obligation by making it more flexible and less definitive, while still maintaining professionalism and clarity.",
    "contradiction_score": 0.03174690902233124,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 695,
    "start_char": 472950,
    "end_char": 476758,
    "original": "develop articicial  [***] of [***] growth and [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] 4  [***]/[***]          [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] [***] Lines, [***]  lines [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] Desk study of state of art in industry [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] Discuss with PM what could Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission    be done quickly to demonstrate feasibility        [***] [***] [***] [***]   [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] CERES -IGER SCHEDULE 1    April 1, 2007 Attachment B - Budget * See page 2 Page 1 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission 2007/8   2008/9   2009/10 No of Months   12.00   12.00   12.00 SALARY    [***]   [***]   [***] NI [***]%    [***]   [***]   [***] super [***]%    [***]   [***]   [***] PAY COSTS    [***]   [***]   [***] OTHER RECURRENT CONSUMABLES    [***]   [***]   [***] CONSUMABLES MOLECULAR BIO    [***]   [***]   [***] CASUAL & OVERTIME    [***]   [***]   [***] TRAVEL & SUBSISTENCE    [***]   [***]   [***] STUDENTSHIP (PhD)    [***]   [***]   [***] SUB - TOTAL    [***]   [***]   [***] OTHER COSTS ESTATES COST    [***]   [***]   [***] RECRUITMENT    [***]   [***]   [***] ANALYTICAL CHEMISTRY    [***]   [***]   [***] CONTROLLED ENVIRONMENT    [***]   [***]   [***] BIOINFORMATICS    [***]   [***]   [***] ULTRASTRUCTURE & IMMUNOLOGY    [***]   [***]   [***] MASS SPECTOMETRY    [***]   [***]   [***] SEQUENCING    [***]   [***]   [***] EXTENSION TECHNOLOGIES    [***]   [***]   [***] TRANSFORMATION TECHNOLOGIES    [***]   [***]   [***] SEED STORE    [***]   [***]   [***] ROAD VEHICLES    [***]   [***]   [***] AGRI VEHICLES    [***]   [***]   [***] FARM    [***]   [***]   [***] GLASSHOUSE    [***]   [***]   [***] SUB CONT    [***]   [***]   [***] TOTAL OTHER COSTS    [***]   [***]   [***] OVERHEAD COSTS* ESTABLISHMENT SERVICES    [***]   [***]   [***] ADMIN SERVICES    [***]   [***]   [***] INSTITUTE & SITE MANAGEMENT    [***]   [***]   [***] FEC NOTIONAL INSURANCE    [***]   [***]   [***] CAPITAL CHARGE    [***]   [***]   [***] DEPARTMENT    [***]   [***]   [***] TOTAL OVERHEAD COSTS    [***]   [***]   [***] TOTAL    [***]   [***]   [***] CERES payment for reasonable perf    [***]   [***]   [***] CERES payment for full completion    [***]   [***]   [***] TOTAL paid by CERES    [***]   [***]   [***] SURPLUS OVER TOC    [***]   [***]   [***] CERES -IGER SCHEDULE 1    April 1, 2007 Attachment B \u2014 Budget This Budget is agreed upon for contract years 1 through 3. A contract year ( \u201cYear\u201d) is April 1 \u2014 March 31, starting April 1, 2007. CERES agrees to provide funding for IGER \u2019s RESEARCH PROJECT  activities covered by this SCHEDULE in accordance with Article 1.8 of the CA as set forth in the Budget in page 1 of this Attachment B , taking into account what is provided hereinafter.  Pay Costs, Other Recurrent and Other Costs are as in the Budget. Overhead Costs will be payable as  follows:",
    "ollama_generated": "In order to adapt the original clause slightly, let's modify it to shift some responsibilities and provide more flexibility for the project team:\n\nClause:\nThe Artificial [***] development for [***] growth and [***] [***] [***] [***] will be undertaken as per the agreed schedule [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***] The project team will initiate discussions with the Project Manager to swiftly determine potential actions for Confidential Treatment Requested and the Redacted Material, which has been separately submitted to the Commission, to demonstrate feasibility.\n\nHowever, it is important to note that while the team will make every effort to adhere to the proposed schedule and budget outlined in CERES - IGER SCHEDULE 1 as of April 1, 2007 (Attachment B \u2013 Budget), there may be circumstances beyond our control that necessitate adjustments to the timeline or budget. In such cases, we will communicate any deviations promptly and work collaboratively with CERES to find mutually agreeable solutions.\n\nThe original budget is agreed upon for contract years 1 through 3, with each contract year ( \u201cYear\u201d) spanning April 1 \u2013 March 31, commencing on April 1, 2007. CERES will provide funding for IGER's RESEARCH PROJECT activities as outlined in this SCHEDULE, in accordance with Article 1.8 of the CA, taking into account the provisions herein. The Pay Costs, Other Recurrent, and Other Costs are as per the budget. Overhead costs will be payable as follows:\n\n* Establishment Services\n* Administrative Services\n* Institute & Site Management\n* FEC Notional Insurance\n* Capital Charge\n* Department\n\nThe total of these overhead costs will constitute the Total Overhead Costs. The total of all costs, including Pay Costs, Other Recurrent, Other Costs, and Total Overhead Costs, will represent the Total Project Costs.\n\nCERES will make payments to IGER for reasonable performance as well as for full project completion in accordance with the provisions outlined in this document. The total amount paid by CERES will cover the Total Project Costs, with any surplus over and above going towards IGER.\n\nThis Budget serves as a guide for contract years 1 through 3, and while we aim to adhere strictly to it, flexibility may be required to ensure the successful completion of the RESEARCH PROJECT. Any deviations from the budget or timeline will be communicated promptly and addressed collaboratively with CERES.",
    "contradiction_score": 0.043264683336019516,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 697,
    "start_char": 477194,
    "end_char": 477437,
    "original": "-  Furthermore, CERES will pay for Year 1 an additional [***]% of the asked overhead (  i.e.[***]% in total of the asked overhead) for full completion of the Year 1 items A and B  listed hereinafter. This additional [***]% equals [***] pounds.",
    "ollama_generated": "- Conversely, it is understood that CERES will bear an extra [***]% of the total overhead requested as a bonus payment for satisfactorily completing all Year 1 items A and B, as detailed herein. This additional [***]% amounts to approximately [***] pounds.\n\nIn this version, the obligation on CERES is now framed as a bonus rather than an addition to the original cost, making it weaker compared to the original clause.",
    "contradiction_score": 0.01465042494237423,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 702,
    "start_char": 478332,
    "end_char": 478572,
    "original": "CERES -IGER SCHEDULE 1    April 1, 2007 Attachment B \u2014 Budget Suggested milestones, for discussion, for full overhead payments The Parties agree to finalize this document within thirty (30) days from the commencement  date of this SCHEDULE.",
    "ollama_generated": "CERES - IGER SCHEDULE 1, April 1, 2007, Attachment B \u2013 Budget\nSuggested milestones, for discussion, for full overhead payments\n\nThe Parties acknowledge that the completion of this document may require a certain degree of time and collaboration. To facilitate an efficient process, the parties shall strive to reach finalization within a thirty (30) day window following the initiation date of this SCHEDULE, but understand that unforeseen circumstances may extend the deadline. Any deviations from this timeline should be communicated promptly between the parties to ensure mutual understanding and adjustments as needed.",
    "contradiction_score": 0.004526658449321985,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 723,
    "start_char": 495865,
    "end_char": 497377,
    "original": "Mb 185 Miscanthus [***]   [***] Mb 186 Miscanthus [***]   [***] Mb 187 Miscanthus [***]   [***] Mb 188 Miscanthus [***]   [***] Mb 189 Miscanthus [***]   [***] under MTA Mb 190 Miscanthus [***]   [***] under MTA Mb 191 Miscanthus [***]   [***] Mb 192 Miscanthus [***]   [***] Mb 193 Miscanthus [***]   [***] Mb 194 Miscanthus [***]   [***] Mb 195 Miscanthus [***]   [***] List of Donated Accessions Mb 196 Miscanthus [***]   [***] Mb 197 Miscanthus [***]   [***] Mb 198 Miscanthus [***]   [***] Mb 199 Miscanthus [***]   [***] Mb 200 Miscanthus [***]   [***] Mb 201 Miscanthus [***]   [***] Mb 202 Miscanthus [***]   [***] Mb 203 Miscanthus [***]   [***] Mb 204 Miscanthus [***]   [***] Mb 205 Miscanthus [***]   [***] Mb 206 Miscanthus [***]   [***] Mb 207 Miscanthus [***]   [***] Mb 208 Miscanthus [***]   [***] Mb 209 Miscanthus [***]   [***] Mb 210 Miscanthus [***]   [***] Mb 211 Miscanthus [***]   [***] Mb 212 Miscanthus [***]   [***] Mb 213 Miscanthus [***]   [***] Mb 214 Miscanthus [***]   [***] Mb 215 Miscanthus [***]   [***] Mb 216 Miscanthus [***]   [***] Mb 217 Miscanthus [***]   [***] Mb 218 Miscanthus [***]   [***] Mb 219 Miscanthus [***]   [***] Mb 220 Miscanthus [***]   [***] Mb 221 Miscanthus [***]   [***] under MTA Mb 222 Miscanthus [***]   [***] under MTA Mb 223 Miscanthus [***]   [***] under MTA Mb 224 Miscanthus [***]   [***] under MTA Mb 225 Miscanthus [***]   [***] under MTA Mb 226 Miscanthus [***]   [***] under MTA Mb 227 Miscanthus [***]   [***] under MTA No longer retained.",
    "ollama_generated": "The following Miscanthus accessions, namely Mb 185 Miscanthus [***]   [***], Mb 186 Miscanthus [***]   [***], Mb 187 Miscanthus [***]   [***], ..., Mb 203 Miscanthus [***]   [***], Mb 204 Miscanthus [***]   [***], Mb 205 Miscanthus [***]   [***], ..., Mb 217 Miscanthus [***]   [***], Mb 218 Miscanthus [***]   [***], Mb 219 Miscanthus [***]   [***], and Mb 220 Miscanthus [***]   [***], are no longer the responsibility of the donor under the Material Transfer Agreement (MTA). The receiving party shall now maintain custody and control over these accessions.\n\nIn this revised clause, the obligation for maintaining the Miscanthus accessions has been shifted from the donor to the receiving party. Additionally, it emphasizes that the donor is no longer responsible for these accessions.",
    "contradiction_score": 0.0035558161325752735,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 724,
    "start_char": 497377,
    "end_char": 497690,
    "original": "Mb 228 Miscanthus [***]   [***] under MTA Mb 229 Miscanthus [***]   [***] under MTA Mb 230 Miscanthus [***]   [***] under MTA Mb 231 Miscanthus [***]   [***] under MTA Mb 232 Miscanthus [***]   [***] under MTA Mb 233 Miscanthus [***]   [***] under MTA Mb 234 Miscanthus [***]   [***] under MTA No longer retained.",
    "ollama_generated": "The following Miscanthus, specifically those under MTA Mb 228, Mb 229, Mb 230, Mb 231, Mb 232, and Mb 233 Miscanthus, no longer remain in our possession or control under the respective MTAs. We hereby relinquish any further obligations or responsibilities associated with their maintenance, cultivation, or exploitation as outlined in these agreements. However, we shall continue to comply with any existing contractual obligations concerning intellectual property rights, data sharing, and confidentiality.",
    "contradiction_score": 0.006194078363478184,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 728,
    "start_char": 499456,
    "end_char": 499631,
    "original": "Mb 278 Miscanthus [***]   [***] no MTA Mb 279 Miscanthus [***]   [***] no MTA Mb 280 Miscanthus [***]   [***] no MTA Mb 281 Miscanthus [***]   [***] no MTA No longer retained.",
    "ollama_generated": "Upon the termination of this Agreement, all rights and obligations regarding the cultivation and management of Miscanthus, as outlined in MTA Mb 278, Mb 279, Mb 280, and Mb 281, shall no longer be the responsibility of the Party hereto. Instead, the receiving Party shall assume all rights and obligations pertaining to these Miscanthus strains without further notice or claim.",
    "contradiction_score": 0.03795560821890831,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 734,
    "start_char": 499999,
    "end_char": 500057,
    "original": "Mb 289 Miscanthus [***]   [***] no MTA No longer retained.",
    "ollama_generated": "Mb 289: The party holding Miscanthus [***] [***] shall have the discretion to release their hold, should an active Master Tenancy Agreement (MTA) not be applicable at the time of such decision.",
    "contradiction_score": 0.23528695106506348,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 741,
    "start_char": 502233,
    "end_char": 502372,
    "original": "AMENDMENT I to SCHEDULE 1 between CERES, INC. and INSTITUTE OF GRASSLAND AND ENVIRONMENTAL RESEARCH dated April  1, 2007 (the \u201cSchedule \u201d).",
    "modified": "ALTERATION III to ADDENDUM A, pertaining to the contractual relationship between CERES, INC. and THE INSTITUTE OF GRASSLAND AND ENVIRONMENTAL RESEARCH, originally established on April 1, 2007 (hereinafter referred to as \"Addendum A\" ).\n\nIn this revised version, the order of the parties involved has been inverted and the term \"Schedule\" has been replaced with \"Addendum A\". This slight modification shifts the focus towards the Institute of Grassland and Environmental Research, positioning them first in the contractual relationship.",
    "contradiction_score": 0.9234685301780701,
    "kept": true
  },
  {
    "clause_index": 765,
    "start_char": 510328,
    "end_char": 510495,
    "original": "CONFIDENTIAL AMENDMENT III to the SCHEDULE 1 between the Institute of Biological, Environmental and Rural Sciences ( \u201cIBERS\u201d) of Aberystwyth University and Ceres, Inc.",
    "ollama_generated": "CONFIDENTIAL MODIFICATION III to the SCHEDULE 1 between Ceres, Inc. ( \"CERES\") and the Institute of Biological, Environmental and Rural Sciences ( \u201cIBERS\u201d) of Aberystwyth University\n\nIn this modified version, the original party initiating the confidentiality agreement (Aberystwyth University's IBERS) is now the receiving party, while Ceres, Inc. takes on the role of the disclosing party. This subtle shift in naming positions the clause to reflect a situation where Ceres, Inc. will be sharing confidential information with Aberystwyth University's IBERS.",
    "contradiction_score": 0.039685480296611786,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 766,
    "start_char": 510495,
    "end_char": 510558,
    "original": "(\u201cCERES\u201d) and dated April 1, 2007, as amended ( \u201cSchedule  1\u201d).",
    "ollama_generated": "(\"Schedule 1\") and dated April 1, 2007, as amended (hereinafter referred to as the \"Agreement\"), it is understood that any obligations or liabilities arising from this Agreement shall be borne primarily by the other party, unless otherwise specified.\n\nThis modification highlights a shift of responsibility for obligations and liabilities from the party mentioned in the original clause to the opposite party, unless explicitly stated otherwise.",
    "contradiction_score": 0.0019614933989942074,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 768,
    "start_char": 510624,
    "end_char": 510688,
    "original": "WHEREAS, the initial term of Schedule 1 was for three (3) years;",
    "ollama_generated": "NOTWITHSTANDING, the original tenure of Schedule 1 was for a period of three (3) years;\n\nThis change implies that although the initial term of Schedule 1 was for three years, there may be circumstances or conditions that allow for variations or extensions beyond this period, unlike the original clause which states the term explicitly.",
    "contradiction_score": 0.01659024879336357,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 769,
    "start_char": 510688,
    "end_char": 510804,
    "original": "WHEREAS, the Parties wish to extend the term of Schedule 1 to cover additional research and  development activities;",
    "ollama_generated": "WHEREAS, one Party expresses a willingness to allow for an extension of Schedule 1's term, at its sole discretion, to accommodate further research and development activities, with no such obligation imposed upon the other.",
    "contradiction_score": 0.3408192992210388,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 770,
    "start_char": 510804,
    "end_char": 510888,
    "original": "WHEREAS, IBERS and CERES further wish to amend Schedule 1, as set forth hereinafter.",
    "ollama_generated": "WHEREAS, CERES and IBERS desire to make modifications to the terms outlined in Schedule 1, as detailed below. This amendment is to be considered at their discretion, without any binding obligation on either party to do so unless mutually agreed upon.",
    "contradiction_score": 0.0017059118254110217,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 777,
    "start_char": 512092,
    "end_char": 512293,
    "original": "Page 2 of 9      PLAN  (Attachment A/2010 revision ), and FUNDING (Article 6 of this  SCHEDULE). \u201d 5. The Parties agree that this Amendment III is deemed to have become effective as of  March 31, 2010.",
    "ollama_generated": "Page 2 of 9\n    PLAN (Attachment A/2010 revision), and FUNDING (Article 6 of this SCHEDULE). \"5. Effective from March 31, 2010, the Parties acknowledge that the effectiveness of Amendment III is contingent upon all requisite approvals being obtained.\"\n\nIn this version, the original clause states that the amendment became effective on a specific date, while the revised clause makes the effectiveness of the amendment dependent on obtaining all necessary approvals before it becomes effective. This shifts the responsibility from the parties to ensure the amendment was effective as of a certain date to a condition where the amendment's effectiveness is contingent upon approval(s) being granted.",
    "contradiction_score": 0.007394327782094479,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 778,
    "start_char": 512293,
    "end_char": 512404,
    "original": "6. For the remainder, Schedule 1 remains unchanged and this Amendment III shall form an  integral part thereof.",
    "ollama_generated": "6. With respect to any matters not explicitly addressed in this Amendment III, the provisions of Schedule 1 shall continue to apply, but without prejudice to the overarching nature of this Amendment as a distinct and independent instrument.",
    "contradiction_score": 0.01276489719748497,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 785,
    "start_char": 514313,
    "end_char": 514847,
    "original": "Page 4 of 9 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission Action proposed   Dates Performed   Summary of action taken 4. Send [***] of  the best selections from  [***] and [***] to [***] identified  by June 2010 October [***] Miscanthus samples for [***] under [***] on behalf of  Dr. Charlie Rodgers. The Miscanthus [***] in this package  are provided under a research agreement between IBERS and  CERES and are restricted to release only to CERES, Inc.  They are not [***].",
    "ollama_generated": "Page 4 of 9 Confidential Treatment Requested and the Redacted Material has been separately filed with the Commission. Action proposed is subject to the discretion of identified individuals within [***] and any action taken shall be reported by June 2010 October [***]. Miscanthus samples for [***] under [***] are requested from Dr. Charlie Rodgers on behalf of CERES, Inc., with delivery anticipated by June 2010 October [***]. It is to be noted that the Miscanthus samples in this package are provided under a research agreement between IBERS and CERES, Inc., and their release is restricted solely to CERES, Inc. These Miscanthus samples may not be utilized for any purpose other than the research project specified.",
    "contradiction_score": 0.0058808051981031895,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 786,
    "start_char": 514847,
    "end_char": 515204,
    "original": "6. Develop knowledge of [***] for [***] in a wide range of [***] in order to [***]    April \u2014 Oct [***] experiments were run in 2010.  Discovery of the [***] effect when plants were grown under simulated [***] conditions.5. Create [***] based on a knowledge of  [***] available   All year and ongoing   Table shows number of  [***] attempted by [***] types.",
    "ollama_generated": "6. Familiarize oneself with the broad spectrum of [***] related to [***], for the purpose of enhancing [***]. Ongoing experiments in simulated [***] environments, primarily from April to October, were conducted as early as 2010. The discovery of the significant [***] effect on plant growth under these conditions is noteworthy.\n\n5. Develop the ability to generate [***] utilizing insights gained from a comprehensive understanding of [***]. This ongoing process is applicable year-round. Data presented in the table represents the number of attempts made by various [***] types.\n\nChanges made:\n- Strengthened the emphasis on the continuous and broad knowledge acquisition (changed \"Develop knowledge\" to \"Familiarize oneself with a broad spectrum\" and \"Create\" to \"Develop the ability to generate\").\n- Inverted the condition by stating that the experiments were conducted from April to October instead of specifying the period after which the discovery was made.\n- Shifted the responsibility of providing [***] knowledge by changing \"Create based on a knowledge of\" to \"Utilizing insights gained from a comprehensive understanding of\".",
    "contradiction_score": 0.14822480082511902,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 788,
    "start_char": 515580,
    "end_char": 515715,
    "original": "In 2010 encumbrances ([***] and [***]) stopped us going down the route of [***] M. [***] with the well  characterized [***] from [***].",
    "ollama_generated": "In 2010, the existence of encumbrances ([***] and [***]) prevented us from pursuing the path of [***] M. [***] with the well, whose nature was clearly defined as [***], located at [***]. Instead, it became our responsibility to find an alternative solution or course of action.",
    "contradiction_score": 0.0006530939135700464,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 792,
    "start_char": 517078,
    "end_char": 517505,
    "original": "[***] (when plants are [***] ([***]  years from planting)  [***] status in autumn [***] (scores and measurements) 2. Development of [***]/ [***] with desirable characters Ongoing Attempt >[***] exploratory [***]  between [***] in [***] of the [***]  Perform at least [***] with best [***]  identified in [***] using the [***] and  [***] in 2010 From these [***] of [***] and [***] with  interesting [***] to be sent to Charlie.",
    "ollama_generated": "[***/***/***/***/**] (Once plants have surpassed the [***/***-year mark following planting], they are expected to achieve maturity by autumn, as indicated by their scores and measurements. Continuous Effort > The exploration of [***/***/***/***/**] with desirable traits is encouraged, not guaranteed, between parties in [***/***/***/***/**] during the cultivation period. Strive for a minimum of [***/***/***/***/**] attempts with the most promising [***/***/***/***/**] identified in [***/***/***/***/**], utilizing the [***/***/***/***/**] and [***/***/***/***/**] established in 2010. From these [***/***/***/***/**] of [***/***/***/***/**] and [***/***/***/***/**], any intriguing [***/***/***/***/**] discovered will be shared with Charlie for further investigation.\n\nIn this revised clause, the obligation to explore and develop plants with desirable traits has been softened from \"Perform at least\" to \"encouraged, not guaranteed.\" Additionally, responsibility for finding the most promising plants has shifted from an explicit requirement to a recommendation (\"strive for a minimum\"). Lastly, the language emphasizing that exploration is ongoing (\"ongoing attempt\") has been replaced with \"continuous effort,\" suggesting less urgency or commitment.",
    "contradiction_score": 0.06634314358234406,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 797,
    "start_char": 519313,
    "end_char": 519389,
    "original": "6. [***] experiments       Field experiments with direct sowing using [***].",
    "modified": "6. The Company reserves the right to conduct, at its sole discretion, trials or indirect experiments involving the application of [***], without any obligation to perform field experiments with direct sowing using [***].",
    "contradiction_score": 0.862926721572876,
    "kept": true
  },
  {
    "clause_index": 798,
    "start_char": 519389,
    "end_char": 519695,
    "original": "7. Reporting       Minutes and powerpoints from meetings Attachment B/2010 revision Budget CERES shall pay IBERS \u00a3[***] ( GBP) per year for the implementation of the RESEARCH AND  DEVELOPMENT PLAN set forth in Attachment A/2010 revision. Annual payments from CERES to IBERS  shall not exceed \u00a3[***] ( GBP).",
    "ollama_generated": "7. Submission and Accessibility of Meeting Minutes and Presentations (Revised Attachment B/2010)\nIBERS shall have the right to access and utilize the RESEARCH AND DEVELOPMENT PLAN as outlined in Attachment A/2010 revision, at no cost. IBERS may request CERES for an annual review of this plan, with the understanding that any additional costs incurred by CERES for such reviews shall be borne solely by CERES, and shall not exceed their discretionary budget.",
    "contradiction_score": 0.0427592396736145,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 801,
    "start_char": 520417,
    "end_char": 520694,
    "original": "Institute of Biological, Environmental and Rural Sciences ( \u201cIBERS\u201d) of Aberystwyth University Plas Gogerddan Aberystwyth Ceredigion SY23 3EB United Kingdom \u201d Page 9 of 9 Confidential Treatment Requested and the Redacted Material has been separately filed with  the Commission.",
    "ollama_generated": "The following obligation is hereby shifted to the party receiving this agreement, concerning the Institute of Biological, Environmental and Rural Sciences ( \"IBERS\"), Aberystwyth University, Plas Gogerddan, Aberystwyth, Ceredigion SY23 3EB, United Kingdom. It is understood that this recipient shall be responsible for maintaining the confidentiality of any information or material marked as \"Confidential Treatment Requested\" and shall file any redacted materials separately with the Commission, should they deem it necessary. This clause supersedes any previous understanding regarding the handling of such confidential information.",
    "contradiction_score": 0.21161405742168427,
    "kept": false,
    "reason": "low_contradiction"
  }
]